{{Distinguish|人格分裂|思覺失調}}
{{NoteTA|
|T = zh-cn:精神分裂症; zh-hk:精神分裂症; zh-tw:思覺失調症;
|G1 = ME
|1 =zh-cn:精神分裂; zh-hk:精神分裂; zh-tw:思覺失調;
|2 =zh:利培酮;zh-hans:利培酮;zh-hant:利培酮;zh-cn:利培酮;zh-tw:理思必妥;zh-hk:維思通;zh-sg:利培酮;zh-mo:利培酮;
|3 =zh-tw:一等親; zh-cn:一级亲属;
|4 =zh-cn:阿尔茨海默病; zh-tw:阿茲海默症; zh-hk:阿爾茲海默氏症;
|5 =zh-cn:痴呆症; zh-hk:認知障礙症; zh-tw:失智症;
|6 =zh-hans:进化;zh-hant:進化;zh-hk:進化;zh-tw:演化;zh-cn:进化;zh-sg:进化;zh-mo:進化;
|7 =zh-tw:正性;zh-hk:陽性;zh-cn:阳性;
|8 =zh-tw:負性;zh-hk:陰性;zh-cn:阴性;
|9 =zh-hans:抑郁; zh-hk:抑鬱; zh-tw:憂鬱;
}}
{{medical}}
{{Infobox medical condition (new)
| name = 思覺失調症<br/>schizophrenia
| image = [[File:Artistic_view_of_how_the_world_feels_like_with_schizophrenia_-_journal.pmed.0020146.g001.jpg|250px]]
| caption = 思覺失調症患者的[[自畫像|自畫像]]，表達個人對疾病所引起的現實扭曲經歷的看法。
| field = [[精神科|精神科]]
| pronounce = {{IPAc-en|ˌ|s|k|ɪ|t|s|ə|ˈ|f|r|iː|n|i|ə|,_|ˌ|s|k|ɪ|d|z|-|,_|-|oʊ|-|,_|-|ˈ|f|r|ɛ|n|i|ə}}<ref>{{Citation |last=Jones |first=Daniel|title=English Pronouncing Dictionary |editors=Peter Roach, James Hartmann and Jane Setter |place=Cambridge |publisher=Cambridge University Press |orig-year=1917 |year=2003 |isbn=3-12-539683-2 }}</ref>
| symptoms        = [[妄想|錯誤信念]]（{{lang-en|false beliefs}}）、[[思维障碍|思維紊亂]]、[[幻聽|聽到其他人聽不見的聲音]]<ref name=WHO2015/><ref name=NIH2016/>
| onset           = 16-30歲<ref name=NIH2016/>
| duration        = 持續一段長時間<ref name=NIH2016/>
| causes          = 環境及遺傳因子<ref name=Lancet2016/>
| risks           = {{link-en|家族史|Family_history_(medicine)}}、[[吸食大麻|吸食大麻]]、於胎內發展時出現問題、在城市中長大、擁有較大年紀的父親<ref name=Lancet2016/><ref name=LachanceMcKenzie2014 />
| diagnosis       =依據求診者所表現出來的行為及其所主訴的個人經歷作診斷<ref name=DSM5pg101/>
| differential    =[[物質濫用|物質濫用]]、[[情感障礙|情感障礙]]、[[亨丁頓舞蹈症|亨丁頓舞蹈症]]、[[自閉症|自閉症]]<ref>{{cite book|last1=Ferri|first1=Fred F.|title=Ferri's differential diagnosis : a practical guide to the differential diagnosis of symptoms, signs, and clinical disorders|date=2010|publisher=Elsevier/Mosby|location=Philadelphia, PA|isbn=0323076998|page=Chapter S|edition=2nd ed.}}</ref>
| prevention      =
| treatment       = 辅导、职业培训<ref name=Lancet2016/><ref name=WHO2015/>
| medication      = [[抗精神病藥|抗精神病藥]]<ref name=Lancet2016/>
| prognosis       = 鑑於患者自殺以及患上心脏病等文明病的風險增加<ref name="SBU2012">{{Cite web|url=http://www.sbu.se/en/publications/sbu-assesses/schizophrenia--pharmacological-treatments-patient-involvement-and-organization-of-care/|title=Medicinal treatment of psychosis/schizophrenia|last=|first=|date=2012-11-21|website=www.sbu.se|publisher=Swedish Agency for Health Technology Assessment and Assessment of Social Services|language=en|archive-url=|archive-date=|dead-url=|access-date=2017-06-26}}</ref>，所以其預期壽命下降了18-20年<ref name=Lauren2012/><ref name="SBU2012"/>
| frequency       = ~0.5%<ref name=Lancet09/>
| deaths          = ~17,000（2015）<ref name=GDB2015/>
}}
'''思覺失調症'''（{{lang-la|Schizophrenia}}）是[[精神疾病|精神疾病]]的一種<ref name=WHO2015/>。其特徵為患者出現[[異常行為|異常的行為]]和不能理解什麼是真實的<ref name=WHO2015>{{cite web|title=Schizophrenia Fact sheet N°397 |url=http://www.who.int/mediacentre/factsheets/fs397/en/ |website=WHO |accessdate=2016-02-03 |date=2015-09 |deadurl=no |archiveurl=https://web.archive.org/web/20161018051507/http://www.who.int/mediacentre/factsheets/fs397/en/ |archivedate=2016-10-18 }}</ref>。台灣、中國大陸和香港以往皆譯作精神-{}-分裂-{}-症，乃直譯拉丁文名稱「Schizophrenia」而來<ref name="直譯">{{Cite web |url=http://www.sop.org.tw/Dsm5/Folder/2012_04/20121209.pdf |title=Schizophrenia中文診斷名稱意見調查說明 |author=黃敏偉 |publisher=台灣精神醫學會 |accessdate=2016-11-18 |deadurl=yes |archiveurl=https://web.archive.org/web/20131126113944/http://www.sop.org.tw/Dsm5/Folder/2012_04/20121209.pdf |archivedate=2013-11-26 }}</ref>，台灣後來則改譯為「-{zh-hans:[[思觉失调|思觉失调]]症;zh-hant:[[思覺失調|思覺失調]]症}-」<ref name="更名">{{Cite web|url=http://www.mohw.gov.tw/cht/Ministry/DM2_P.aspx?f_list_no=7&fod_list_no=4558&doc_no=45300 |title=您知道嗎?「精神分裂症」已經更名為「思覺失調症」 |publisher=中華民國衛生福利部 |date=2014-06-24 |accessdate=2016-11-30 |deadurl=no |archiveurl=https://web.archive.org/web/20160817182937/http://www.mohw.gov.tw/news/455845300 |archivedate=2016-08-17 }}</ref>。常見的症狀包括[[妄想|錯誤信念]]（false beliefs），不易瞭解或混亂的思維，聽到其他人聽不見的聲音，[[妄想|妄想]]、[[幻覺|幻覺]]、[[幻聽|幻聽]]、社會參與和情緒表達的程度減少，以及缺乏動機<ref name=WHO2015/><ref name=NIH2016>{{cite web|title=Schizophrenia |url=http://www.nimh.nih.gov/health/topics/schizophrenia/index.shtml |website=National Institute of Mental Health |accessdate=2016-02-03 |date=2016-01 |deadurl=no |archiveurl=https://web.archive.org/web/20161125145206/https://www.nimh.nih.gov/health/topics/schizophrenia/index.shtml |archivedate=2016-11-25 }}</ref>。思覺失調症患者通常伴有其他心理上的健康問題，例如[[焦慮症|焦慮症]]、[[临床抑郁症|临床抑郁症]]或[[物質濫用|藥物濫用]]障碍<ref name="Sim_et_al_2006">{{cite journal |author1=Buckley PF |author2=Miller BJ |author3=Lehrer DS |author4=Castle DJ |title=Psychiatric comorbidities and schizophrenia |journal=Schizophr Bull |volume=35 |issue=2 |pages=383–402 |date=2009-03 |pmid=19011234 |pmc=2659306 |doi=10.1093/schbul/sbn135}}</ref>。症狀通常逐漸地出現，且一般在成年早期開始，並持續一段長時間<ref name=NIH2016/><ref name=DSM5pg101>{{cite book| author= American Psychiatric Association |title= Diagnostic and Statistical Manual of Mental Disorders |publisher= American Psychiatric Publishing |location= Arlington |isbn= 978-0890425558 |pages= 101–105 |edition=5th}}</ref>。

精神分裂症的成因包括環境因子及[[遺傳|遺傳]]因子<ref name=Lancet2016>{{cite journal|last1=Owen|first1=MJ|last2=Sawa|first2=A|last3=Mortensen|first3=PB|title=Schizophrenia.|journal=Lancet (London, England)|date=2016-01-14|pmid=26777917|doi=10.1016/S0140-6736(15)01121-6}}</ref>。可能的環境因子包括在城市中長大、濫用[[娛樂性藥物|娛樂性藥物]]、某些传染病、父母年齡，和自身在母體內時營養攝取不足<ref name=Lancet2016/><ref name=Chadwick2013>{{cite journal |author1=Chadwick B |author2=Miller ML |author3=Hurd YL |title=Cannabis Use during Adolescent Development: Susceptibility to Psychiatric Illness |journal=Front Psychiatry |volume=4 |issue= |pages=129 |year=2013 |pmid=24133461 |pmc=3796318 |doi=10.3389/fpsyt.2013.00129|type=Review}}</ref>。遺傳因子則包括各種常見和罕見的遺傳變異<ref name="KavanaghTansey2014">{{cite journal|last1=Kavanagh|first1=D H|last2=Tansey|first2=K E|last3=O'Donovan|first3=M C|last4=Owen|first4=M J|title=Schizophrenia genetics: emerging themes for a complex disorder|journal=Molecular Psychiatry|volume=20|issue=1|year=2014|pages=72–76|issn=1359-4184|doi=10.1038/mp.2014.148}}</ref>。精神分裂症可依據求診者所表現出來的行為及其所主訴的個人經歷作診斷<ref name=DSM5pg101/>。在診斷時，還必須把求診者的文化背景納入考慮範圍之內<ref name=DSM5pg101/>。截至2013年為止，此病並沒有任何客观的測試予供作診斷<ref name=DSM5pg101/>。精神分裂症並不等同「多重人格」或「多重人格障礙」——這種混淆的想法常在公眾的認知中出現<ref name=BMJ07>{{cite journal |author1=Picchioni MM |author2=Murray RM |title=Schizophrenia |journal=BMJ |volume=335 |issue=7610 |pages=91{{subst:一字线}}95 |date=2007-07 |pmid=17626963 |pmc=1914490 |doi=10.1136/bmj.39227.616447.BE}}</ref>。

治療的重心是為患者處方[[抗精神病药|抗精神病药]]，以及安排諮詢、工作培訓和社會康復<ref name=WHO2015/><ref name=Lancet2016>{{cite journal|last1=Owen|first1=MJ|last2=Sawa|first2=A|last3=Mortensen|first3=PB|title=Schizophrenia.|journal=Lancet (London, England)|date=2016-01-14|pmid=26777917|doi=10.1016/S0140-6736(15)01121-6}}</ref>。目前尚不清楚{{link-en|典型抗精神病藥|Typical antipsychotic}}與{{link-en|非典型抗精神病藥|Atypical antipsychotic}}兩者間哪種的效果會較佳<ref name=Kane2010>{{cite journal |author1=Kane JM |author2=Correll CU |title=Pharmacologic treatment of schizophrenia |journal=Dialogues Clin Neurosci |volume=12 |issue=3 |pages=345–57 |year=2010 |pmid=20954430 |pmc=3085113}}</ref>。在其他抗精神病藥物都無法改善病情的情況下，就可能會使用[[氯氮平|氯氮平]]。必要時，可能會強制患者住院治療，如患者可能會對自身或他人構成傷害这一種情況，但現在的住院時間比以往更為短暫，且強制住院治療的總次數亦較为少<ref name="BeckerKilian2006">{{cite journal |author1=Becker T |author2=Kilian R |year=2006 |title=Psychiatric services for people with severe mental illness across western Europe: what can be generalized from current knowledge about differences in provision, costs and outcomes of mental health care? |journal=Acta Psychiatrica Scandinavica Supplement |volume=113 |pages=9{{subst:一字线}}16 |pmid=16445476 |doi=10.1111/j.1600-0447.2005.00711.x |issue=429}}</ref>。

世界人口中約0.3－0.7％在其一生中受精神分裂症所影響<ref name=Lancet09>{{cite journal |author=van Os J, Kapur S |title=Schizophrenia |journal=Lancet |volume=374 |issue=9690 |pages=635{{subst:一字线}}645 |date=2009-08 |pmid=19700006 |doi=10.1016/S0140-6736(09)60995-8 |url=http://xa.yimg.com/kq/groups/19525360/611943554/name/Schizophrenia+-+The+Lancet.pdf |deadurl=yes |archiveurl=https://web.archive.org/web/20160303223217/http://xa.yimg.com/kq/groups/19525360/611943554/name/Schizophrenia%2B-%2BThe%2BLancet.pdf |archivedate=2016-03-03 |access-date=2016-10-17 }}</ref> 。2018年，全球估計有超過2300萬名精神分裂症患者<ref name="management Schizophrenia"/>。男性比女性更常受到精神分裂症的影響<ref name=WHO2015/>，且其病情也一般較嚴重。大約20％的人康復得很好，一些人亦能完全康復<ref name=DSM5pg101/>；50％的人则终生受到一定程度的影響<ref name=Law2015>{{cite book | last1 = Lawrence | first1 = Ryan E. | last2 = First | first2  =Michael B. | last3 = Lieberman | first3 = Jeffrey A. | name-list-format = vanc | chapter = Chapter 48: Schizophrenia and Other Psychoses | editor-first1 = Allan | editor-last1 = Tasman | editor-first2 = Jerald | editor-last2 = Kay | editor-first3 = Jeffrey A. | editor-last3 = Lieberman | editor-first4 = Michael B. | editor-last4 = First | editor-first5 = Michelle B. | editor-last5 = Riba | title = Psychiatry | edition = fourth | date = 2015 | pages = 798, 816, 819 | doi = 10.1002/9781118753378.ch48 | publisher=John Wiley & Sons, Ltd | isbn = 978-1-118-84547-9 }}</ref>。患者常伴有一定的社會問題，例如長期失業、貧窮和無家可歸<ref name=DSM5pg101/><ref>{{cite journal|last1=Foster|first1=A|last2=Gable|first2=J|last3=Buckley|first3=J|title=Homelessness in schizophrenia.|journal=The Psychiatric clinics of North America|date=2012-09|volume=35|issue=3|pages=717–34|pmid=22929875|doi=10.1016/j.psc.2012.06.010}}</ref>。患有精神分裂症的人的平均[[預期壽命|預期壽命]]比平均值少10年至25年<ref name=Lauren2012>{{cite journal|vauthors=Laursen TM, Munk-Olsen T, Vestergaard M |title=Life expectancy and cardiovascular mortality in persons with schizophrenia|journal=Current opinion in psychiatry|date=2012-03|volume=25|issue=2|pages=83{{subst:一字线}}88|pmid=22249081|doi=10.1097/YCO.0b013e32835035ca}}</ref>。其背後原因是患者的身體健康問題增加和自殺率較高（約5%）<ref name=Lancet09/><ref name=Jop2010>{{cite journal|author1=Hor K |author2=Taylor M |title=Suicide and schizophrenia: a systematic review of rates and risk factors |journal=Journal of psychopharmacology (Oxford, England)|date=2010-11|volume=24|issue=4 Suppl|pages=81–90|pmid=20923923|doi=10.1177/1359786810385490}}</ref>。在2015年，全球估計有17,000人死於與精神分裂症有關或由其引起的行為<ref name=GDB2015>{{cite journal|last1=GBD 2015 Mortality and Causes of Death|first1=Collaborators.|title=Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015.|journal=Lancet (London, England)|date=2016-10-08|volume=388|issue=10053|pages=1459{{subst:一字线}}1544|pmid=27733281|doi=10.1016/s0140-6736(16)31012-1}}</ref>。

== 症狀 ==
{{See also|精神分裂症的基本症狀}}
[[File:August_Natterer_Meine_Augen_zur_Zeit_der_Erscheinungen.jpg|thumb]]
[[File:Cloth_embroidered_by_a_schizophrenia_sufferer.jpg|thumb]]
精神分裂症患者可能會出现的症狀包括[[幻觉|幻覺]]（大多數是以[[幻聽|幻聽]]的形式出現）、[[妄想|妄想]]（性質通常是較为不合理的，或感到被逼害），以及[[思维障碍|思維和言語紊亂]]。思維和言語紊亂的程度可從較輕微的思維不清晰，以至較嚴重的胡言亂語。患者亦普遍出現社交退縮、對穿衣和衛生不感興趣，以及失去動力和判斷力的情況<ref name=CarsonNursing>{{cite book|last1=Carson|first1=Verna Benner| name-list-format = vanc |title=Mental Health Nursing: The Nurse-patient Journey|date=2000|publisher=W.B. Saunders|isbn=978-0-7216-8053-8|page=638|url=https://books.google.com/books?id=QM5rAAAAMAAJ|language=en|deadurl=no|archiveurl=https://web.archive.org/web/20160513011255/https://books.google.com/books?id=QM5rAAAAMAAJ|archivedate=2016-05-13}}</ref>。

精神分裂症患者亦常見出現{{link-en|自我體驗異常| Distortions of self-experience}}的症狀，例如認為一些想法或感覺不是真正屬於自己的，而是{{link-en|他者所植入的|Thought insertion}}，這種症狀有時稱為「被動體驗」<ref name="Heinz_2016">{{cite journal | vauthors = Heinz A, Voss M, Lawrie SM, Mishara A, Bauer M, Gallinat J, Juckel G, Lang U, Rapp M, Falkai P, Strik W, Krystal J, Abi-Dargham A, Galderisi S | display-authors = 6 | title = Shall we really say goodbye to first rank symptoms? | journal = European Psychiatry | volume = 37 | pages = 8–13 | date = September 2016 | pmid = 27429167 | doi = 10.1016/j.eurpsy.2016.04.010 }}</ref>。常在患者身上觀察出情感障碍，例如缺乏积极的情緒反应<ref name="HirschWeinberger2003p21">{{cite book | vauthors = Hirsch SR, Weinberger DR | title = Schizophrenia | url = https://books.google.com/books?id=x3fmsV55rigC&pg=PA21 |year=2003|publisher=Wiley-Blackwell|isbn=978-0-632-06388-8|page=21|deadurl=no|archiveurl=https://web.archive.org/web/20150320131542/http://books.google.com/books?id=x3fmsV55rigC&pg=PA21|archivedate=2015-03-20}}</ref>。{{link-en|社會認知|Social cognition}}障礙也與精神分裂症有關<ref>{{cite journal | vauthors = Brunet-Gouet E, Decety J | title = Social brain dysfunctions in schizophrenia: a review of neuroimaging studies | journal = Psychiatry Research | volume = 148 | issue = 2–3 | pages = 75–92 | date = December 2006 | pmid = 17088049 | doi = 10.1016/j.pscychresns.2006.05.001 }}</ref>，例如患者所表現出來的多疑症狀。患者亦常面臨[[社會孤立|社會孤立]]。普遍患者還在以下範疇出現困難：[[工作记忆|工作记忆]]、[[长期记忆|长期记忆]]和学习、[[管控功能|管控功能]]、[[注意|注意力]]<ref name=Lancet09/>。在一種罕見的亞型中，患者會經常保持緘默、在異常姿勢中保持不動，或者表現出亳無理由的兴奋狀態——都是[[紧张性抑郁障碍|緊張性抑鬱障礙]]的症狀<ref>{{cite journal |author1=Ungvari GS |author2=Caroff SN |author3=Gerevich J |title=The catatonia conundrum: evidence of psychomotor phenomena as a symptom dimension in psychotic disorders |journal=Schizophr Bull |volume=36 |issue=2 |pages=231–8 |date=2010-03  |pmid=19776208 |doi=10.1093/schbul/sbp105 |pmc=2833122}}</ref>。患者亦會發現自己對面部表情的感知存有一定困難<ref>{{cite journal|author1=Kohler CG |author2=Walker JB |author3=Martin EA |author4=Healey KM |author5=Moberg PJ |title=Facial emotion perception in schizophrenia: a meta-analytic review |journal=Schizophr Bull |volume=36 |issue=5 |pages=1009–19 |date=2010-09 |pmid=19329561 |pmc=2930336 |doi=10.1093/schbul/sbn192 |url=http://schizophreniabulletin.oxfordjournals.org/content/36/5/1009.full |deadurl=no |archiveurl=https://web.archive.org/web/20150725211920/http://schizophreniabulletin.oxfordjournals.org/content/36/5/1009.full |archivedate=2015-07-25 }}</ref>。部分患者會出現{{link-en|思想阻斷|Thought blocking}}的現象，亦即其在說話時會突然停頓數秒至數分<ref>{{cite book|title=Current diagnosis & treatment psychiatry|date=2008|publisher=McGraw-Hill Medical|location=New York|isbn=978-0-07-142292-5 |page=48|edition=2nd}}</ref><ref>{{cite book | last1 = Oyebode | first1 = Femi | name-list-format = vanc | title = Sims' Symptoms in the Mind E-Book: Textbook of Descriptive Psychopathology|date=2014|publisher=Elsevier Health Sciences|isbn=978-0-7020-5555-3|page=152|url=https://books.google.com/books?id=lnVYBAAAQBAJ&pg=PA152|language=en}}</ref>。

大約30％至50％的精神分裂症患者不能接受自己患病的事實，或遵從推薦予他們的治療<ref>{{cite journal|author=Baier M|title=Insight in schizophrenia: a review|journal=Current psychiatry reports|date=2010-08|volume=12|issue=4|pages=356–61|pmid=20526897|doi=10.1007/s11920-010-0125-7}}</ref>。精神分裂症的治療可能會對患者的洞察力産生一些影響<ref>{{cite journal|author1=Pijnenborg GH |author2=van Donkersgoed RJ |author3=David AS |author4=Aleman A |title=Changes in insight during treatment for psychotic disorders: a meta-analysis|journal=Schizophrenia Research|date=2013-03|volume=144|issue=1–3|pages=109–17|pmid=23305612|doi=10.1016/j.schres.2012.11.018}}</ref>。

精神分裂症患者可能比一般人有較高的比率患上[[大腸激躁症|大腸激躁症]]，但除非特別提及此一問題，否則他們通常不会特別指出<ref>{{cite journal|last1=Fadgyas-Stanculete|first1=M|last2=Buga|first2=AM|last3=Popa-Wagner|first3=A|last4=Dumitrascu|first4=DL|title=The relationship between irritable bowel syndrome and psychiatric disorders: from molecular changes to clinical manifestations.|journal=Journal of molecular psychiatry|year=2014|volume=2|issue=1|pages=4|pmid=25408914|doi=10.1186/2049-9256-2-4}}</ref>。{{link-en|精神性多渴症|Primary polydipsia}}在精神分裂症患者中相对較普遍<ref>{{cite book|last1=Goroll|first1=Allan H.|last2= Mulley |first2=Albert G. | name-list-format = vanc |title=Primary Care Medicine: Office Evaluation and Management of The Adult Patient: Sixth Edition|date=2011|publisher=Lippincott Williams & Wilkins|isbn=978-1-4511-2159-9|page=Chapter 101|url=https://books.google.com/books?id=fXpKo1afC2YC&pg=PT1766|language=en}}</ref>。
=== 陽性及陰性症狀 ===
精神分裂症通常以陽性及陰性症狀來描述<ref name="Sims_2002">{{cite book |author=Sims A |title=Symptoms in the mind: an introduction to descriptive psychopathology |publisher=W. B. Saunders |location=Philadelphia |year=2002 |isbn=0-7020-2627-1 }}</ref>。陽性症狀是大多數人通常不會遇到的症狀，但存在於精神分裂症患者中。這包括妄想、思維和言語紊亂，以及在五感上存有幻覺——這些通常被認為是[[思覺失調|精神病]]的表現<ref>Kneisl C. and Trigoboff E. (2009). Contemporary Psychiatric- Mental Health Nursing. 2nd edition. London: Pearson Prentice Ltd. p. 371</ref>。幻覺通常與妄想的主題內容有關<ref name=DSM299/>。藥物對治療患者的陽性症狀十分有效<ref name="DSM299">American Psychiatric Association. Task Force on DSM-IV. (2000). Diagnostic and statistical manual of mental disorders: DSM-IV-TR. American Psychiatric Pub. ISBN 978-0-89042-025-6. p. 299</ref>。

陰性症狀是指正常情緒反應或其他思維過程中所存有的一些缺陷，藥物對治療陰性症狀的效果較差<ref name=CarsonNursing/>。其包括缺乏情感或{{link-en|情緒淡然|Reduced affect display}}（Reduced affect display）、{{link-en|貧語症|Alogia}}（Alogia）、[[享樂不能|享樂不能]]（Anhedonia，快樂不起來）、[[無社會性|無社會性]]（Asociality）和{{link-en|動機缺乏|Avolition}}（Avolition）。與陽性症狀相比，陰性症狀對他人的負擔、患者的生活質量以及工作能力的影響較大<ref>{{cite journal|vauthors=Velligan DI, Alphs LD |lastauthoramp=yes |title=Negative Symptoms in Schizophrenia: The Importance of Identification and Treatment |journal=Psychiatric Times |volume=25 |issue=3 |date=2008-03-01 |url=http://www.psychiatrictimes.com/schizophrenia/article/10168/1147581 |deadurl=no |archiveurl=https://web.archive.org/web/20091006015627/http://www.psychiatrictimes.com/schizophrenia/article/10168/1147581 |archivedate=2009-10-06 }}</ref>。擁有較為嚴重的陰性症狀的患者在發病之前通常具有適應不良的生活史，並且藥物對其治療效果通常亦是十分有限<ref name=CarsonNursing/><ref name=AFP10>{{cite journal |author1=Smith T |author2=Weston C |author3=Lieberman J |title=Schizophrenia (maintenance treatment) |journal=Am Fam Physician |volume=82 |issue=4 |pages=338–9 |date=2010-08  |pmid=20704164 }}</ref>。

多於一項的变量分析研究對「陽性及陰性」这一區分表示質疑，並按其觀察把症狀分成三個維度。儘管用語會有所差異，但大多會將其分成人格解体、幻覺及陰性症狀<ref>{{cite book|last1=Buxbaum|first1=Joseph|last2=Sklar|first2=Pamela|last3=Nestler|first3=Eric|last4=Charney|first4=Dennis| name-list-format = vanc |title=Neurobiology of Mental Illness|date=2013|publisher=Oxford University Press|isbn=978-0-19-993495-9|edition=4th|chapter=17}}</ref>。

===認知功能障礙===
一般認為認知能力的缺陷是精神分裂症的核心特徵<ref name="Bozikas_2011">{{cite journal | vauthors = Bozikas VP, Andreou C | title = Longitudinal studies of cognition in first episode psychosis: a systematic review of the literature | journal = The Australian and New Zealand Journal of Psychiatry | volume = 45 | issue = 2 | pages = 93–108 | date = February 2011 | pmid = 21320033 | doi = 10.3109/00048674.2010.541418 | url = http://anp.sagepub.com/content/45/2/93 | archiveurl = https://web.archive.org/web/20161130110259/http://anp.sagepub.com/content/45/2/93  | deadurl = no | archivedate = 2016-11-30 }}</ref><ref>{{cite journal | vauthors = Dauvermann MR, Whalley HC, Schmidt A, Lee GL, Romaniuk L, Roberts N, Johnstone EC, Lawrie SM, Moorhead TW | title = Computational neuropsychiatry - schizophrenia as a cognitive brain network disorder | journal = Frontiers in Psychiatry | volume = 5 | pages = 30 | date = 2014-01-01 | pmid = 24723894 | pmc = 3971172 | doi = 10.3389/fpsyt.2014.00030 | url = http://journal.frontiersin.org/article/10.3389/fpsyt.2014.00030/abstract | archiveurl = https://web.archive.org/web/20160319181939/http://journal.frontiersin.org/article/10.3389/fpsyt.2014.00030/abstract  | deadurl = no | archivedate = 2016-03-19 }}</ref><ref name="Shah_2012">{{cite journal | vauthors = Shah JN, Qureshi SU, Jawaid A, Schulz PE | title = Is there evidence for late cognitive decline in chronic schizophrenia? | journal = The Psychiatric Quarterly | volume = 83 | issue = 2 | pages = 127–44 | date = June 2012 | pmid = 21863346 | doi = 10.1007/s11126-011-9189-8 }}</ref> 。患者的認知缺陷程度是個體功能、工作表現的質量，以及维持治疗效度的預測因素<ref name="Goldberg_2010">{{cite journal | vauthors = Goldberg TE, Keefe RS, Goldman RS, Robinson DG, Harvey PD | title = Circumstances under which practice does not make perfect: a review of the practice effect literature in schizophrenia and its relevance to clinical treatment studies | journal = Neuropsychopharmacology | volume = 35 | issue = 5 | pages = 1053–62 | date = April 2010 | pmid = 20090669 | pmc = 3055399 | doi = 10.1038/npp.2009.211 | url = http://www.nature.com/npp/journal/v35/n5/full/npp2009211a.html | archiveurl = https://web.archive.org/web/20160207215956/http://www.nature.com/npp/journal/v35/n5/full/npp2009211a.html  | deadurl = no | archivedate = 2016-02-07 }}</ref>。認知功能障礙的存在及其程度是一項比起陽性或陰性症狀更為良好的指標去評估個體功能<ref name="Bozikas_2011" />。受認知功能缺陷所影響的範疇十分广泛，其中包括[[工作记忆|工作记忆]]、[[长期记忆|长期记忆]]<ref name="Kurtz_2001">{{cite journal | vauthors = Kurtz MM, Moberg PJ, Gur RC, Gur RE | title = Approaches to cognitive remediation of neuropsychological deficits in schizophrenia: a review and meta-analysis | journal = Neuropsychology Review | volume = 11 | issue = 4 | pages = 197–210 | date = December 2001 | pmid = 11883669 | doi = 10.1023/A:1012953108158 | url = https://link.springer.com/article/10.1023/A%3A1012953108158 }}</ref><ref name="Tan_2009">{{cite journal | vauthors = Tan BL | title = Profile of cognitive problems in schizophrenia and implications for vocational functioning | journal = Australian Occupational Therapy Journal | volume = 56 | issue = 4 | pages = 220–8 | date = August 2009 | pmid = 20854522 | doi = 10.1111/j.1440-1630.2008.00759.x | url = http://onlinelibrary.wiley.com/doi/10.1111/j.1440-1630.2008.00759.x/abstract | archiveurl = https://web.archive.org/web/20161113193319/http://onlinelibrary.wiley.com/doi/10.1111/j.1440-1630.2008.00759.x/abstract  | deadurl = no | archivedate = 2016-11-13 }}</ref>、[[外顯記憶|口語敘述記憶]]<ref>{{cite journal | vauthors = Cirillo MA, Seidman LJ | title = Verbal declarative memory dysfunction in schizophrenia: from clinical assessment to genetics and brain mechanisms | journal = Neuropsychology Review | volume = 13 | issue = 2 | pages = 43–77 | date = June 2003 | pmid = 12887039 | doi = 10.1023/A:1023870821631 }}</ref>、{{link-en|語意處理過程|Semantic processing}}<ref>{{cite journal | vauthors = Pomarol-Clotet E, Oh TM, Laws KR, McKenna PJ | title = Semantic priming in schizophrenia: systematic review and meta-analysis | journal = The British Journal of Psychiatry | volume = 192 | issue = 2 | pages = 92–7 | date = February 2008 | pmid = 18245021 | doi = 10.1192/bjp.bp.106.032102 | url = http://bjp.rcpsych.org/content/192/2/92 | archiveurl = https://web.archive.org/web/20160525012443/http://bjp.rcpsych.org/content/192/2/92  | deadurl = no | archivedate = 2016-05-25 }}</ref>、[[情节记忆|情节记忆]]<ref name="Goldberg_2010" /> 、[[注意力|注意力]]<ref name=Law2015/> 、學習能力（特別是語言學習）<ref name="Kurtz_2001" /> 。在精神分裂症患者中最明顯的是言語記憶的缺陷，並且不是由注意力不足所致。言語記憶障礙與患者的語意編碼能力（處理與意義有關的信息）下降有關，其被視為長期記憶缺陷的另一已知原因<ref name="Kurtz_2001" />。當給予受試者上面寫有一列單詞的列表時，健康的人會較常記住一些意思積極的詞語（此現像稱為[[波麗安娜效應|波麗安娜效應]]）；然而，精神分裂症患者傾向於不管其涵意如何，一概記住所有詞語，這表明失去愉悦感會使患者對詞語的語義編碼能力受損<ref name="Kurtz_2001" /> 。這些缺陷在患者的病情發展至某種程度前就能發現<ref name="Bozikas_2011" /><ref name="Shah_2012" /><ref name="Barch_2003">{{cite journal|title = Cognition in Schizophrenia Does Working Memory Work?|url = http://cdp.sagepub.com/content/12/4/146|journal = Current Directions in Psychological Science|date = 2003-08-01|issn = 0963-7214|pages = 146–150|volume = 12|issue = 4|doi = 10.1111/1467-8721.01251|first = Deanna M.|last = Barch | name-list-format = vanc | deadurl = no|archiveurl = https://web.archive.org/web/20161130110838/http://cdp.sagepub.com/content/12/4/146|archivedate = 2016-11-30}}</ref>。精神分裂症患者的一等親和其他高危群體亦表現出一定程度的認知能力缺陷，特別是在工作記憶上<ref name="Barch_2003" />。關於精神分裂症患者的認知缺陷的文獻綜述顯示，該缺陷可能在青春期早期，或早至兒童期时就已經存在<ref name="Bozikas_2011" />。即使隨著時間的推移，認知缺陷在大多數患者中仍傾向保持原来的樣子，少部分患者或因基於環境变数的可識別原因而改變<ref name="Bozikas_2011" /><ref name="Kurtz_2001" />。

雖然「隨著時間的推移，認知缺陷仍傾向保持原来的樣子」的證據是可靠和充分的<ref name="Goldberg_2010" /><ref name="Kurtz_2001" />，但在這個領域的大部分研究都集中於提高注意力和工作記憶的方法<ref name="Kurtz_2001" /><ref name="Tan_2009" />。研究人員曾利用「設立較高或較低的奖赏」以及「提供教育與否」等環境變數去嘗試改善患者的學習能力，結果顯示：較高的奖赏會使患者的表現更差，而提供教育則能改善患者的表現，這顯示可能存在一些改善認知表現的治療<ref name="Kurtz_2001" />。可通過口語表達訓練，改善患者的思維、注意力和語言行為；亦可通過認知複誦（cognitive rehearsal），給予患者自我教導（self-instructions），其能使患者在處理困擾的處境時有一套應對表现，以及令在患者在成功時自我強化（self-reinforcement）：這都能顯著提高回憶任務（recall tasks）的表現<ref name="Kurtz_2001" />。這種類型的訓練稱為「自我教導訓練」（self-instructional training），它所產生的好處包括能使患者毫無意義的言語減少，以及改善患者的回憶能力和注意力<ref name="Kurtz_2001" />。

===發病===
青春期晚期至成年人早期是精神分裂症發病的高峰<ref name=Lancet09/>，這亦是青壯年人社會和職業發展的關鍵年齡<ref name="Addington_et_al_2007"/>。經診斷患有精神分裂症的人中，分別有40％和23％的男性及女性在19歲之前就表現出該病的症狀<ref name=Cullen>{{cite journal|vauthors=Cullen KR, Kumra S, Regan J, etal |title=Atypical Antipsychotics for Treatment of Schizophrenia Spectrum Disorders |journal=Psychiatric Times |volume=25 |issue=3 |year=2008 |url=http://www.psychiatrictimes.com/schizophrenia/article/10168/1147536 |deadurl=no |archiveurl=https://web.archive.org/web/20081228153056/http://www.psychiatrictimes.com/schizophrenia/article/10168/1147536 |archivedate=2008-12-28 |deadurl=no |archiveurl=https://web.archive.org/web/20081228153056/http://www.psychiatrictimes.com/schizophrenia/article/10168/1147536 |archivedate=2008-12-28 }}</ref>。精神分裂症的症狀一般在16-30歲期間首次出現<ref name="NIH2016" /><ref name="DSM5pg101" />。大多男性患者在18-25歲期間發病，女性患者則大多在25-35歲之間發病<ref name="OchoaLabad2012">{{cite journal | vauthors = Ochoa S, Usall J, Cobo J, Labad X, Kulkarni J | title = Gender differences in schizophrenia and first-episode psychosis: a comprehensive literature review | journal = Schizophrenia Research and Treatment | volume = 2012 | pages = 916198 | year = 2012 | pmid = 22966451 | pmc = 3420456 | doi = 10.1155/2012/916198 | type = Review}}</ref>。為了讓與精神分裂症相關的發展障礙的程度減至最低，研究人員已經進行了許多用以鑑定和治療該病的{{link-en|前驅期|Prodrome}}的研究，使精神分裂症在早至發病前30個月就能发现<ref name="Addington_et_al_2007">{{cite journal | vauthors = Addington J, Cadenhead KS, Cannon TD, Cornblatt B, McGlashan TH, Perkins DO, Seidman LJ, Tsuang M, Walker EF, Woods SW, Heinssen R | title = North American Prodrome Longitudinal Study: a collaborative multisite approach to prodromal schizophrenia research | journal = Schizophrenia Bulletin | volume = 33 | issue = 3 | pages = 665–72 | date = May 2007 | pmid = 17255119 | pmc = 2526151 | doi = 10.1093/schbul/sbl075 }}</ref>。在發病前，當事人可能會經歷可以自我控制或短暫的精神病症狀<ref name="Amminger_et_al_2006">{{cite journal  |vauthors=Amminger GP, Leicester S, Yung AR, etal |year=2006 |title=Early onset of symptoms predicts conversion to non-affective psychosis in ultra-high risk individuals |journal=Schizophrenia Research |volume=84 | issue=1 |pages=67–76 |pmid=16677803 |doi=10.1016/j.schres.2006.02.018}}</ref>，和社交退縮、易怒、[[煩躁|煩躁不安]]、動作笨拙這些非特異性症狀<ref name=Coyle>{{cite book  |author=Coyle, Joseph |editor= Siegal, George J|title=Basic Neurochemistry: Molecular, Cellular and Medical Aspects |edition=7th |year=2006 |publisher=Elsevier Academic Press |location=Burlington, MA |isbn=0-12-088397-X |pages=876–78 |chapter=Chapter 54: The Neurochemistry of Schizophrenia|display-editors=etal}}</ref><ref name="ParnasJorgensen1989">{{cite journal | vauthors = Parnas J, Jorgensen A | title = Pre-morbid psychopathology in schizophrenia spectrum | journal = The British Journal of Psychiatry | volume = 155 | issue = 5 | pages = 623–7 | date = November 1989 | pmid = 2611591 | doi =  10.1192/s0007125000018109}}</ref>。發展精神分裂症的兒童可能會有的表現包括智力下降、動作發展遲緩、偏好於獨自玩樂、社交焦慮和學習成績差<ref>{{cite journal | vauthors = Khandaker GM, Barnett JH, White IR, Jones PB | title = A quantitative meta-analysis of population-based studies of premorbid intelligence and schizophrenia | journal = Schizophrenia Research | volume = 132 | issue = 2–3 | pages = 220–7 | date = November 2011 | pmid = 21764562 | doi = 10.1016/j.schres.2011.06.017 | pmc=3485562}}</ref><ref>{{cite journal | vauthors = Welham J, Isohanni M, Jones P, McGrath J | title = The antecedents of schizophrenia: a review of birth cohort studies | journal = Schizophrenia Bulletin | volume = 35 | issue = 3 | pages = 603–23 | date = May 2009 | pmid = 18658128 | pmc = 2669575 | doi = 10.1093/schbul/sbn084 }}</ref><ref>{{cite journal | vauthors = Dickson H, Laurens KR, Cullen AE, Hodgins S | title = Meta-analyses of cognitive and motor function in youth aged 16 years and younger who subsequently develop schizophrenia | journal = Psychological Medicine | volume = 42 | issue = 4 | pages = 743–55 | date = April 2012 | pmid = 21896236 | doi = 10.1017/s0033291711001693 | url = https://www.researchgate.net/publication/51623569_Meta-analyses_of_cognitive_and_motor_function_in_youth_aged_16_years_and_younger_who_subsequently_develop_schizophrenia | archiveurl = https://web.archive.org/web/20170202022622/https://www.researchgate.net/publication/51623569_Meta-analyses_of_cognitive_and_motor_function_in_youth_aged_16_years_and_younger_who_subsequently_develop_schizophrenia  | deadurl = no | archivedate = 2017-02-02 }}</ref>。

==病因==
遺傳和環境因素的配合在精神分裂症的病情發展中扮演了一個關鍵的角色<ref name=BMJ07/><ref name=Lancet09/>。若急性短暫性精神病患者擁有與精神分裂症有關的家族病患史，其在一年後診斷為精神分裂症的機率約有20％-40％<ref name="Drake_Lewis_2005">{{cite journal |author1=Drake RJ |author2=Lewis SW |title=Early detection of schizophrenia |journal=Current Opinion in Psychiatry |volume=18 |issue=2 |pages=147–50 |date=2005-03  |pmid=16639167 |doi=10.1097/00001504-200503000-00007}}</ref>。

===遺傳因子===
據估計，精神分裂症的[[遗传度|遗传度]]为80％，這表示80％的精神分裂症個體患病風險差異可由基因方面的差異來解釋<ref name=Her2011/>。該些估計的差异很大，因為難以把遺傳因子和環境因子的影響区分<ref name="ODonovan_et_al_2003">{{cite journal |author1=O'Donovan MC |author2=Williams NM |author3=Owen MJ |title=Recent advances in the genetics of schizophrenia |journal=Hum. Mol. Genet. |volume=12 Spec No 2 |pages=R125–33 |date=2003-10  |pmid=12952866 |doi=10.1093/hmg/ddg302}}</ref>。發病的最大單一危險因子是{{link-en|一等親|first-degree relative}}（包括父母、子女和手足）中有人患有精神分裂症（風險為6.5％）；若同卵雙胞胎中其中一方是精神分裂症患者，另一方則有超過40％的機會也受到精神分裂症的影響<ref name=BMJ07/>。如果雙親中其中一位患有精神分裂症，其子女患上精神分裂症的風險約為13％；如果雙親分別都患有精神分裂症，風險則將近50％<ref name=Her2011>{{cite book|author=Herson M|title=Adult psychopathology and diagnosis |year=2011 |publisher=John Wiley & Sons |isbn=9781118138847 |url=https://books.google.com/books?id=iJtzm1KfU5oC&pg=PT282 |chapter= Etiological considerations}}</ref>。有關精神分裂症{{link-en|候選基因|Candidate gene}}的研究結果一般不能找到一致的相關性<ref>{{cite journal | vauthors = Farrell MS, Werge T, Sklar P, Owen MJ, Ophoff RA, O'Donovan MC, Corvin A, Cichon S, Sullivan PF | title = Evaluating historical candidate genes for schizophrenia | journal = Molecular Psychiatry | volume = 20 | issue = 5 | pages = 555–62 | date =  2015 | pmid = 25754081 | pmc = 4414705 | doi = 10.1038/mp.2015.16 }}</ref>。

目前已知許多[[基因|基因]]與精神分裂症有關，每組都對精神分裂症有少許的影響，以及人類現時尚末完全了解每組基因的傳遞和表達<ref name="KavanaghTansey2014"/><ref>{{cite journal | vauthors = Schork AJ, Wang Y, Thompson WK, Dale AM, Andreassen OA | title = New statistical approaches exploit the polygenic architecture of schizophrenia--implications for the underlying neurobiology | journal = Current Opinion in Neurobiology | volume = 36 | pages = 89–98 | date = February 2016 | pmid = 26555806 | pmc = 5380793 | doi = 10.1016/j.conb.2015.10.008 }}</ref>。多基因遗传评分的结果顯示，該些基因最少可以解釋7％精神分裂症的易患性變異<ref>{{cite journal | vauthors = Kendler KS | title = The Schizophrenia Polygenic Risk Score: To What Does It Predispose in Adolescence? | journal = JAMA Psychiatry | volume = 73 | issue = 3 | pages = 193–4 | date = March 2016 | pmid = 26817666 | doi = 10.1001/jamapsychiatry.2015.2964 | url = http://jamanetwork.com/journals/jamapsychiatry/fullarticle/2484484 }}</ref>。約5％的精神分裂症個案可部分歸因於罕見的{{link-en|拷貝數變異|Copy-number variation}}，包括22q11、1q21以及16p11<ref name="Lowther 82">{{cite journal | vauthors = Lowther C, Costain G, Baribeau DA, Bassett AS | title = Genomic Disorders in Psychiatry-What Does the Clinician Need to Know? | journal = Current Psychiatry Reports | volume = 19 | issue = 11 | pages = 82 | date = September 2017 | doi = 10.1007/s11920-017-0831-5 | pmid = 28929285 }}</ref>。該些罕見的拷貝數變異會使個體發展精神分裂症的机会增加最多20倍，當事人亦常伴發自閉症和智能障礙<ref name="Lowther 82"/>。

2018年6月，《[[科學_(期刊)|科學]]》期刊發表一篇統合分析初步發現，思覺失調症和[[躁鬱症|躁鬱症]]、[[重性抑郁障碍|憂鬱症]]、和[[注意力不足過動症|注意力不足過動症]]有許多共同的可能致病基因。<ref name="The Brainstorm Consortium Anttila Bulik-Sullivan Finucane 2018 p. ">{{cite journal | author=The Brainstorm Consortium | last2=Anttila | first2=Verneri | last3=Bulik-Sullivan | first3=Brendan | last4=Finucane | first4=Hilary K|display-authors=etal|title=Analysis of shared heritability in common disorders of the brain | journal=Science | volume=360 | issue=6395 | date=2018-06-22 | issn=0036-8075 | pmid=29930110 | doi=10.1126/science.aap8757 | url=http://science.sciencemag.org/content/360/6395/eaap8757 | access-date=2018-07-28 | page= | archive-url=https://web.archive.org/web/20180703004653/http://science.sciencemag.org/content/360/6395/eaap8757 | archive-date=2018-07-03 | dead-url=no }}</ref>

===環境因子===
與精神分裂症的病發相關的環境因子包括生活環境、使用藥物，以及產前壓力<ref name=Lancet09/>。

母体应激跟患上精神分裂症的風險增加有關，而這可能是[[络丝蛋白|络丝蛋白]]所致的。現有觀察指母体应激會導致络丝蛋白的啟動子高度甲基化，繼令其失表达；在動物模型中這會引致GABA能神经元數量減少——此一現象常見於精神分裂症患者當中<ref>{{cite journal | vauthors = Negrón-Oyarzo I, Lara-Vásquez A, Palacios-García I, Fuentealba P, Aboitiz F | title = Schizophrenia and reelin: a model based on prenatal stress to study epigenetics, brain development and behavior | journal = Biological Research | volume = 49 | pages = 16 | date = 2016 | pmid = 26968981 | pmc = 4787713 | doi = 10.1186/s40659-016-0076-5 }}</ref>。孕婦營養缺乏和肥胖皆可能是精神分裂症的風險因子。现有證據亦表明母體壓力及感染會令像[[白细胞介素-8|白细胞介素-8]]和腫瘤壞死因子般的促炎症蛋白質產生，繼而影響胎兒的神經發展<ref>{{cite journal | vauthors = Brown AS | title = The environment and susceptibility to schizophrenia | journal = Progress in Neurobiology | volume = 93 | issue = 1 | pages = 23–58 | date = 2011 | pmid = 20955757 | pmc = 3521525 | doi = 10.1016/j.pneurobio.2010.09.003 }}</ref><ref>{{cite journal | vauthors = le Charpentier Y, Hoang C, Mokni M, Finet JF, Biaggi A, Saguin M, Plantier F | title = [Histopathology and ultrastructure of opportunistic infections of the digestive tract in acquired immunodeficiency syndrome] | journal = Archives d'Anatomie et De Cytologie Pathologiques | volume = 40 | issue = 2–3 | pages = 138–49 | date = 2005 | pmc = 1280409 | doi = 10.1289/ehp.7572 | pmid=16140635}}</ref>。

雖然養育方式對精神分裂症的病發並沒有任何重大的影響，但擁有鼓勵型的父母的人，在與擁有批評型或敵對型的父母的人相比之下，他日後的病發機會更低<ref name=BMJ07/>。在兒時心靈受創、父母死亡、成為欺凌或辱罵對象的人，其日後罹患精神病的風險会增加<ref>{{cite journal|author1=Dvir Y |author2=Denietolis B |author3=Frazier JA |title=Childhood trauma and psychosis|journal=Child and adolescent psychiatric clinics of North America|date=2013-10|volume=22|issue=4|pages=629–41|pmid=24012077|doi=10.1016/j.chc.2013.04.006}}</ref>。即使考慮到像[[娛樂性藥物|吸毒]]、[[族群|種族]]和[[社會群體|社會群體]]規模般的因素<ref name="fn_19">{{cite journal |author=Van Os J |year=2004 |title=Does the urban environment cause psychosis? |journal=British Journal of Psychiatry |volume=184 | issue=4 |pages=287–288 |pmid=15056569 |doi=10.1192/bjp.184.4.287}}</ref>，在城市環境中渡過童年生活的人或住在城市的成年人，罹患精神分裂症的風險仍會增加至原本的一倍<ref name=BMJ07/><ref name=Lancet09/>。其他重要因素包括社會孤立、社會逆境相關的移民、種族歧視、家庭困難、失業，和居住條件惡劣<ref name=BMJ07/><ref name="Selten_et_al_2007">{{cite journal |author1=Selten JP |author2=Cantor-Graae E |author3=Kahn RS |date=2007-03  |title=Migration and schizophrenia |journal=Current Opinion in Psychiatry |volume=20 |issue=2 |pages=111–115 |pmid=17278906 |doi=10.1097/YCO.0b013e328017f68e}}</ref>。

已有假設指出，在一些人當中，精神分裂症的病發與{{link-en|腸道功能障礙|Gastrointestinal tract}}有關，例如{{link-en|非乳糜瀉的麩質敏感|Non-celiac gluten sensitivity}}或{{link-en|腸道菌群|Gut flora}}異常<ref name=NemaniHosseini2015>{{cite journal|last1=Nemani|first1=K|last2=Hosseini Ghomi|first2=R|last3=McCormick|first3=B|last4=Fan|first4=X|title=Schizophrenia and the gut-brain axis.|journal=Progress in neuro-psychopharmacology & biological psychiatry|date=2015-01-02|volume=56|pages=155–60|pmid=25240858|doi=10.1016/j.pnpbp.2014.08.018}}</ref>。精神分裂症患者亞組對麩質的免疫反應不同於乳糜瀉患者，麸质过敏症患者的某些血清生物標誌物會升高，例如{{link-en|抗麥醇溶蛋白IgG|Anti-gliadin_antibodies#Anti-gliadin_IgG}}或{{link-en|抗麥醇溶蛋白IgA|Anti-gliadin_antibodies#Anti-gliadin_IgA}}<ref name=LachanceMcKenzie2014>{{cite journal|vauthors=Lachance LR, McKenzie K|title=Biomarkers of gluten sensitivity in patients with non-affective psychosis: a meta-analysis|journal=Schizophr Res|volume=152|issue=2–3|pages=521–7|date=2014-02|pmid=24368154|doi=10.1016/j.schres.2013.12.001|type=Review}}</ref>。

====吸食毒品====
大約一半的精神分裂症患者吸毒、濫藥或攝取過多的酒精<ref name=Gregg2007>{{cite journal |author1=Gregg L |author2=Barrowclough C |author3=Haddock G |year=2007 |title= Reasons for increased substance use in psychosis |journal= Clin Psychol Rev |volume=27 |issue=4 |pages=494–510 |pmid=17240501 |doi=10.1016/j.cpr.2006.09.004}}</ref>。安非他命、可卡因和較小程度的酒精可導致短暫的{{link-en|刺激性精神障礙|Stimulant psychosis}}或{{link-en|與酒精相關的精神障礙|Alcoholic hallucinosis}}，其與精神分裂症十分類似<ref name=BMJ07/><ref name=alcohol>{{cite web|url=http://www.emedicine.com/med/topic3113.htm |title=Alcohol-Related Psychosis |accessdate=2006-09-27 |author=Larson, Michael |date=2006-03-30 |work=eMedicine |publisher=WebMD |deadurl=no |archiveurl=https://web.archive.org/web/20081109011819/http://www.emedicine.com/MED/topic3113.htm |archivedate=2008-11-09 }}</ref>。精神分裂症患者使用[[尼古丁|尼古丁]]的速度比普通人群高出許多，雖然這通常不認定為病因<ref>{{cite journal|vauthors=Sagud M, Mihaljević-Peles A, Mück-Seler D, etal |title=Smoking and schizophrenia |journal=Psychiatr Danub |volume=21 |issue=3 |pages=371–5 |date=2009-09 |pmid=19794359 |url=http://www.hdbp.org/psychiatria_danubina/pdf/dnb_vol21_no3/dnb_vol21_no3_371.pdf |deadurl=no |archiveurl=https://web.archive.org/web/20160304033459/http://www.hdbp.org/psychiatria_danubina/pdf/dnb_vol21_no3/dnb_vol21_no3_371.pdf |archivedate=2016-03-04 }}</ref>。

酒精濫用可能會通過誘發機制，引起活性物質所致的慢性精神障礙<ref name=emedicine>{{EMedicine|med|3113|Alcohol-Related Psychosis}}</ref>。
但使用酒精與早年發病的精神障礙並不相關<ref name=Large2011>{{cite journal |author1=Large M |author2=Sharma S |author3=Compton MT |author4=Slade T |author5=Nielssen O |title=Cannabis use and earlier onset of psychosis: a systematic meta-analysis |journal=Arch. Gen. Psychiatry |volume=68 |issue=6 |pages=555–61 |date=2011-06  |pmid=21300939 |doi=10.1001/archgenpsychiatry.2011.5}}</ref>。

大麻可能是精神分裂症的其中一個{{link-en|大麻精神病|Cannabis and psychosis|誘發因素}}<ref name=Chadwick2013/><ref name=Niesink2013>{{cite journal |author1=Niesink RJ |author2=van Laar MW |title=Does cannabidiol protect against adverse psychological effects of THC? |journal=Frontiers in Psychiatry |volume=4 |pages=130 |year=2013 |pmid=24137134 |pmc=3797438 |doi=10.3389/fpsyt.2013.00130|type=Review }}</ref><ref name=Parakh2013>{{cite journal |author1=Parakh P |author2=Basu D |title=Cannabis and psychosis: have we found the missing links? |journal=Asian Journal of Psychiatry |volume=6 |issue=4 |pages=281–7 |date=2013-08 |pmid=23810133 |doi=10.1016/j.ajp.2013.03.012|type=Review| quote=Cannabis acts as a component cause of psychosis, that is, it increases the risk of psychosis in people with certain genetic or environmental vulnerabilities, though by itself, it is neither a sufficient nor a necessary cause of psychosis.}}</ref>。其可能会令高危人士患上精神分裂症<ref name=Parakh2013/>。患病風險可能在配合某些基因的情況下才會增加<ref name=Parakh2013/>，或可能與先前存在的精神病理有關<ref name= Chadwick2013/>。早年接触[[大麻|大麻]]與患病風險的增加密切相關<ref name=Chadwick2013/>。所增加的程度仍是末知<ref>{{cite journal|last1=Gage|first1=SH|last2=Hickman|first2=M|last3=Zammit|first3=S|title=Association Between Cannabis and Psychosis: Epidemiologic Evidence.|journal=Biological Psychiatry|date=2015-08-12|pmid=26386480|doi=10.1016/j.biopsych.2015.08.001}}</ref>，但患上精神障礙的風險估計是增加了2-3倍<ref name=Niesink2013/>。吸食較高劑量的大麻以及吸食頻率較高这兩項因素與患上慢性精神障礙的風險增加有關<ref name=Niesink2013/>。

患者亦有可能為了消除抑鬱、焦慮、無聊和孤獨這一些負面情緒，而濫用其他藥物<ref name=Gregg2007>{{cite journal |author1=Gregg L |author2=Barrowclough C |author3=Haddock G |year=2007 |title= Reasons for increased substance use in psychosis |journal= Clin Psychol Rev |volume=27 |issue=4 |pages=494–510 |pmid=17240501 |doi=10.1016/j.cpr.2006.09.004}}</ref><ref name=Leweke08>{{cite journal |author1=Leweke FM |author2=Koethe D |title=Cannabis and psychiatric disorders: it is not only addiction |journal=Addict Biol |volume=13 |issue=2 |pages=264–75 |date=2008-06  |pmid=18482435 |doi=10.1111/j.1369-1600.2008.00106.x |url=}}</ref>。

====發育因素====
若胎兒在[[产前发育|母體内發育]]期間經受缺氧不良因素影響，則可能會增加患上精神分裂症的風險<ref name=Lancet09/>。經診斷確實患上精神分裂症的人更可能在冬季或春季出生（至少在[[北半球|北半球]]情況如是），其可能是胎兒接触病毒所致<ref name=BMJ07/>。患病風險因此會增加約5%-8%<ref name=yolken>{{cite journal|journal=Herpes |date=2004-06 |volume=11 |issue=Suppl 2 |pages=83A–88A  |title=Viruses and schizophrenia: a focus on herpes simplex virus|author=Yolken R |pmid=15319094}}</ref>。若懷孕期間或出生時胎兒受到像[[弓形體|弓形體]]般的病原體所感染，其日後的患病機會增加<ref>{{cite journal|last1=Arias|first1=I|last2=Sorlozano|first2=A|last3=Villegas|first3=E|last4=de Dios Luna|first4=J|last5=McKenney|first5=K|last6=Cervilla|first6=J|last7=Gutierrez|first7=B|last8=Gutierrez|first8=J|title=Infectious agents associated with schizophrenia: a meta-analysis.|journal=Schizophrenia Research|date=2012-04|volume=136|issue=1-3|pages=128–36|pmid=22104141|doi=10.1016/j.schres.2011.10.026}}</ref>。

==病理機制==
研究人員已經進行了許多嘗試去解釋大脑功能改變和精神分裂症之間的關係<ref name=Lancet09/>。當中最常見的是{{link-en|多巴胺假說|Dopamine hypothesis of schizophrenia}}，該假説把精神病中所出現的心智缺陷解釋成是因{{link-en|多巴胺能神經元|Dopaminergic pathways}}（dopaminergic neurons）異常所致<ref name=Lancet09/>。
===心理學===
精神分裂症的發病和維持過程中涉及到了很多心理機制。[[認知偏誤|認知偏誤]]常在高危人士或那些经診斷患上精神分裂症的人中发现，尤其是在有壓力或令人困惑的情況下<ref>{{cite journal  |vauthors=Broome MR, Woolley JB, Tabraham P, etal |title=What causes the onset of psychosis? |journal=Schizophr. Res. |volume=79 |issue=1 |pages=23–34 |date=2005-11  |pmid=16198238 |doi=10.1016/j.schres.2005.02.007}}</ref>。一些認知特徵可能反映出整體性{{link-en|神經認知缺陷|Neurocognitive}}（global neurocognitive deficits），如記憶力減退；而其他認知特徵則可能與特定的問題和體驗有關<ref name="Bentall_et_al_2007">{{cite journal |author1=Bentall RP |author2=Fernyhough C |author3=Morrison AP |author4=Lewis S |author5=Corcoran R |year=2007 |title=Prospects for a cognitive-developmental account of psychotic experiences |journal=Br J Clin Psychol |volume=46 | issue=Pt 2 |pages=155–73 |pmid=17524210 | doi = 10.1348/014466506X123011}}</ref><ref name="Kurtz_2005">{{cite journal |author=Kurtz MM |year=2005 |title=Neurocognitive impairment across the lifespan in schizophrenia: an update |journal=Schizophrenia Research |volume=74 | issue=1 |pages=15–26 |pmid=15694750 |doi=10.1016/j.schres.2004.07.005}}</ref>。患者在避免或制止假想中的威脅时，所採取的「防御或攻击性行為」，實際上可能會使妄想[[慢性病|持續化]]<ref name="Freeman_BRT_2007">{{cite journal |author1=Freeman D |author2=Garety PA |author3=Kuipers E |author4=Fowler D |author5=Bebbington PE |author6=Dunn G |title=Acting on persecutory delusions: the importance of safety seeking |journal=Behav Res Ther |volume=45 |issue=1 |pages=89–99 |date=2007-01  |pmid=16530161 |doi=10.1016/j.brat.2006.01.014 |url=}}</ref> 。

儘管已證實患者受到情緒遲鈍的影響，但研究結果表示許多經診斷患有精神分裂症的人是具有情緒感受性的，特別是在緊張或負面刺激的情況下，而且這種感受性可能會加深症狀或疾病本身的嚴重程度<ref name="schizophrenia1">{{cite journal |author1=Cohen AS |author2=Docherty NM |year=2004 |title=Affective reactivity of speech and emotional experience in patients with schizophrenia |journal=Schizophrenia Research |volume=69 | issue=1 |pages=7–14 |pmid=15145465 |doi=10.1016/S0920-9964(03)00069-0 }}</ref><ref>{{cite journal |author1=Horan WP |author2=Blanchard JJ |year=2003 |title=Emotional responses to psychosocial stress in schizophrenia: the role of individual differences in affective traits and coping |journal=Schizophrenia Research |volume=60 | issue=2–3 |pages=271–83 |pmid=12591589 |doi=10.1016/S0920-9964(02)00227-X}}</ref>。一些證據表明妄想的內容和在精神病中患者所體驗到的個人經歷，可以反映出該病背後的情緒性原因，患者如何解釋所體驗到的經歷亦会對症狀有所影響<ref>{{cite journal  |vauthors=Smith B, Fowler DG, Freeman D, etal |title=Emotion and psychosis: links between depression, self-esteem, negative schematic beliefs and delusions and hallucinations |journal=Schizophr. Res. |volume=86 |issue=1–3 |pages=181–8 |date=2006-09  |pmid=16857346 |doi=10.1016/j.schres.2006.06.018}}</ref><ref>{{cite journal |author=Beck, AT |year=2004 |title=A Cognitive Model of Schizophrenia |journal=Journal of Cognitive Psychotherapy |volume=18 | issue=3 |pages=281–88 | doi = 10.1891/jcop.18.3.281.65649}}</ref><ref>{{cite journal |author1=Bell V |author2=Halligan PW |author3=Ellis HD |year=2006 |title=Explaining delusions: a cognitive perspective |journal=Trends in Cognitive Science |volume=10 | issue=5 |pages=219–26 |pmid=16600666 |doi=10.1016/j.tics.2006.03.004}}</ref>。[[心理治療|心理治療]]對症狀的影響被視為一種證據，能更進一步支持心理機制在精神分裂症中所生的作用<ref>{{cite journal |author1=Kuipers E |author2=Garety P |author3=Fowler D |author4=Freeman D |author5=Dunn G |author6=Bebbington P |title=Cognitive, emotional, and social processes in psychosis: refining cognitive behavioral therapy for persistent positive symptoms |journal=Schizophr Bull |volume=32 Suppl 1 |pages=S24–31 |date=2006-10  |pmid=16885206 |pmc=2632539 |doi=10.1093/schbul/sbl014 }}</ref>。

===神經科學===
[[File:Schizophrenia_fMRI_working_memory.jpg|thumb]]（fMRI）比對兩組大腦後的結果；與用以對照的健康人士的大腦相比，患有精神分裂症並以藥物治療的人的大腦橙色區域較少-{zh:（即脑区活化程度較低）;zh-hans:;zh-hant:（即腦區活化程度較低）;zh-cn:（即激活脑区較少）;zh-tw:（即腦區活化程度較低）;zh-hk:（即腦區活化程度較低）}-。]]
[[File:Schizophrenia_(Brain).png|thumb]]的擴大程度有關<ref>{{cite journal|last1=Torres|first1=US|last2=Portela-Oliveira|first2=E|last3=Borgwardt|first3=S|last4=Busatto|first4=GF|title=Structural brain changes associated with antipsychotic treatment in schizophrenia as revealed by voxel-based morphometric MRI: an activation likelihood estimation meta-analysis.|journal=BMC psychiatry|date=2013-12-20|volume=13|pages=342|pmid=24359128|doi=10.1186/1471-244x-13-342}}</ref>。]]
精神分裂症與大脑结构上的異常有關，其能在40％-50％的病例下發現；及在處於急性精神病發作的患者中，能發現其大腦的化學物質失調<ref name=Lancet09/>。使用{{link-en|神经心理测试|Neuropsychological test}}和[[神经成像|神经成像]]技術（如[[功能性磁共振成像|功能性磁共振成像]]（fMRI）和[[正电子发射计算机断层扫描|正电子发射计算机断层扫描]]（PET））檢查大腦活動功能差異的研究顯示，大脑结构上的異常最常發生於[[額葉|額葉]]、[[海马体|海马体]]以及[[颞叶|颞叶]]這些大腦區域上<ref>{{cite book |year=2006 |author1=Kircher, Tilo  |author2=Renate Thienel  |lastauthoramp=yes |title=The Boundaries of Consciousness |isbn=0-444-52876-8 |page=302 |url=https://books.google.com/?id=YHGacGKyVbYC&pg=PA302 |chapter=Functional brain imaging of symptoms and cognition in schizophrenia |publisher=Elsevier |location=Amsterdam}}</ref>。患者的額葉皮層和顳葉區域的體積減少至少於在[[阿兹海默病|阿兹海默病]]患者中所發現的。目前尚不了解這些體積變化是持續進行的，还是在發病之前就已經存在。<ref name=Coyle/>這些「異常」已與精神分裂症相關的{{link-en|神经认知损害|Neurocognitive}}聯繫起來<ref name="Green2006">{{cite journal |author=Green MF |year=2006 |title=Cognitive impairment and functional outcome in schizophrenia and bipolar disorder|journal=Journal of Clinical Psychiatry |volume=67 | issue=Suppl 9 |pages=3–8 |pmid=16965182 |doi=10.4088/jcp.1006e12}}</ref>。因為神經迴路的改變，所以有一些替代性的建議認為精神分裂症應視為一種[[神經發展疾患|神經發展疾患]]<ref name=Insel_2010>{{cite journal |author=Insel TR |title=Rethinking schizophrenia |journal=Nature |volume=468 |issue=7321 |pages=187–93 |date=2010-11  |pmid=21068826 |doi=10.1038/nature09552 }}</ref>。已有爭論圍繞着「使用抗精神病藥治療本身會否引起腦容量減少」這一項問題上<ref>{{cite web|title=Antipsychotics for schizophrenia associated with subtle loss in brain volume |url=http://www.sciencedaily.com/releases/2011/02/110207165438.htm |website=ScienceDaily |accessdate=2014-07-03 |date=2011-02-08 |deadurl=no |archiveurl=https://web.archive.org/web/20160307214311/https://www.sciencedaily.com/releases/2011/02/110207165438.htm |archivedate=2016-03-07 }}</ref>。

許多神经學上的病理研究都著重於{{link-en|中腦邊緣系統路徑|Mesolimbic pathway}}的多巴胺活性。這一聚焦主要是基於一項偶然的發現：阻斷多巴胺活性的藥物——[[吩噻嗪|吩噻嗪]]，可以減少精神病所引致的症狀。此一發現亦為另一項事實所支持：刺激神經細胞釋放[[多巴胺|多巴胺]]的[[安非他命|安非他命]]，可能会加劇精神分裂症的症狀<ref name="Laruelle_et_al_1996">{{cite journal  |vauthors=Laruelle M, Abi-Dargham A, van Dyck CH, etal |title=Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects |journal=Proc. Natl. Acad. Sci. U.S.A. |volume=93 |issue=17 |pages=9235–40 |date=1996-08  |pmid=8799184 |pmc=38625 |doi= 10.1073/pnas.93.17.9235}}</ref>。多巴胺假說亦指出，[[多巴胺受體D2|多巴胺受體D2]]的過度激活是精神分裂症的病因，或/和是出現陽性症狀的原因。儘管所有近20年內常見的抗精神病藥都是基於D2阻斷效應，但在二十世紀九十年代中期[[正电子发射计算机断层扫描|正电子发射计算机断层扫描]]及{{link-en|單光子發射電腦斷層掃描攝影術|Single-photon emission computed tomography}}（SPECT）能提供相關證據支持以前，情況尚不如此。雖然患者的多巴胺受體D2/D3數量會有所增加，但相關效應值很少，且这樣的情況只在未曾用藥的患者當中較為明顯<ref>{{cite journal | vauthors = Howes OD, Kambeitz J, Kim E, Stahl D, Slifstein M, Abi-Dargham A, Kapur S | title = The nature of dopamine dysfunction in schizophrenia and what this means for treatment | journal = Archives of General Psychiatry | volume = 69 | issue = 8 | pages = 776–86 | date = 2012 | pmid = 22474070 | pmc = 3730746 | doi = 10.1001/archgenpsychiatry.2012.169 }}</ref>。一些人體研究已證實患者黑質紋狀體路徑的多巴胺合成方式有所改變<ref>{{cite journal | vauthors = Fusar-Poli P, Meyer-Lindenberg A | title = Striatal presynaptic dopamine in schizophrenia, part II: meta-analysis of [(18)F/(11)C]-DOPA PET studies | journal = Schizophrenia Bulletin | volume = 39 | issue = 1 | pages = 33–42 | date =  2013 | pmid = 22282454 | pmc = 3523905 | doi = 10.1093/schbul/sbr180 }}</ref><ref>{{cite journal | vauthors = Weinstein JJ, Chohan MO, Slifstein M, Kegeles LS, Moore H, Abi-Dargham A | title = Pathway-Specific Dopamine Abnormalities in Schizophrenia | journal = Biological Psychiatry | volume = 81 | issue = 1 | pages = 31–42 | date = 2017 | pmid = 27206569 | pmc = 5177794 | doi = 10.1016/j.biopsych.2016.03.2104 }}</ref>。還有觀察指患者[[前額葉皮質|前額葉皮質]]的多巴胺受體D1活動減退<ref>{{cite journal | vauthors = Salavati B, Rajji TK, Price R, Sun Y, Graff-Guerrero A, Daskalakis ZJ | title = Imaging-based neurochemistry in schizophrenia: a systematic review and implications for dysfunctional long-term potentiation | journal = Schizophrenia Bulletin | volume = 41 | issue = 1 | pages = 44–56 | date = 2015 | pmid = 25249654 | pmc = 4266301 | doi = 10.1093/schbul/sbu132 }}</ref>。D2受體的過度激活和D1受體的活動減退遭研究者認定會擾亂皮质微电路的信噪比，繼而引發認知功能障礙<ref>{{cite journal | vauthors = Winterer G, Weinberger DR | title = Genes, dopamine and cortical signal-to-noise ratio in schizophrenia | journal = Trends in Neurosciences | volume = 27 | issue = 11 | pages = 683–90 | date = 2004 | pmid = 15474169 | doi = 10.1016/j.tins.2004.08.002 }}</ref>。現代的研究人員傾向認为多巴胺假說过於简单，部分原因在於較新的抗精神病藥物（非典型抗精神病藥物）可以跟較舊的抗精神病藥物（典型抗精神病藥物）一樣有效，但都會影響[[血清素|5-羥色胺]]的活性，及可能具有较低的多巴胺阻斷作用<ref name="JonesPilowsky2002">{{cite journal |author1=Jones HM |author2=Pilowsky LS |year=2002 |title=Dopamine and antipsychotic drug action revisited |journal=British Journal of Psychiatry |volume=181 |pages=271–275 |pmid=12356650 |doi=10.1192/bjp.181.4.271}}</ref>。

研究亦聚焦於[[谷氨酸|谷氨酸]]這一種神經遞質，以及[[N-甲基-D-天門冬胺酸受體|NMDA受體]]功能低下在精神分裂症中所扮演的角色，主要原因有兩個：其中一個就是在患者的屍檢中，發現其大腦的{{link-en|谷氨酸受體|Glutamate receptor}}水平異常地低<ref name="fn_27">{{cite journal |author1=Konradi C |author2=Heckers S |year=2003 |title=Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment |journal=Pharmacology and Therapeutics |volume=97 |issue=2 |pages=153–79 |pmid=12559388 |doi=10.1016/S0163-7258(02)00328-5 }}</ref>；另一個則是發現谷氨酸阻斷藥物，如{{link-en|苯環利定|Phencyclidine}}和[[氯胺酮|氯胺酮]]，可以引起類似精神分裂症的症狀和認知問題<ref name="fn_59">{{cite journal |author1=Lahti AC |author2=Weiler MA |author3=Tamara Michaelidis BA |author4=Parwani A |author5=Tamminga CA |year=2001 |title=Effects of ketamine in normal and schizophrenic volunteers |journal=Neuropsychopharmacology |volume=25 |issue=4 |pages=455–67 |pmid=11557159 |doi=10.1016/S0893-133X(01)00243-3 }}</ref>。谷氨酸功能低下與在需用到額葉和海馬功能的測試的表現較差有關。谷氨酸亦影響多巴胺的功能，兩者皆與精神分裂症有關；這些都已顯示谷氨酸神經迴路在精神分裂症中的重要調節作用（和可能的因果關係）<ref name="fn_28">{{cite journal |author1=Coyle JT |author2=Tsai G |author3=Goff D |year=2003 |title=Converging evidence of NMDA receptor hypofunction in the pathophysiology of schizophrenia |journal=Annals of the New York Academy of Sciences |volume=1003 |pages=318–27 |pmid=14684455 |doi=10.1196/annals.1300.020}}</ref>。但谷氨酸藥物對陽性症狀沒有效果<ref name="fn_60">{{cite journal |author1=Tuominen HJ |author2=Tiihonen J |author3=Wahlbeck K |year=2005 |title=Glutamatergic drugs for schizophrenia: a systematic review and meta-analysis |journal=Schizophrenia Research |volume=72 |pages=225–34 |pmid=15560967 |doi=10.1016/j.schres.2004.05.005 |issue=2–3}}</ref>。

==診斷==
精神分裂症是根據[[美國精神醫學學會|美國精神醫學學會]]的[[精神疾病診斷與統計手冊|精神疾病診斷與統計手冊]]第五版（DSM-5）或[[世界衛生組織|世界衛生組織]]的[[ICD-10|國際疾病和相關健康問題統計分類]]（ICD-10）中的標準而作診斷。這些標準的依據为求診者所主訴的個人經歷和他人對求診者的異常行為描述，之後由精神衛生專業人員進行臨床評估。在診斷前，與精神分裂症相關的症狀必須在患者中不斷發生，並需達到一定的嚴重程度。<ref name=BMJ07/>截至2013年為止，此病並沒有任何客觀的測試予供作診斷<ref name=DSM5pg101/>。

===標準===
2013年，美國精神醫學學會發布了{{link-en|精神疾病診斷與統計手冊第五版|DSM-5}}。必須在至少一個月的大部分時間內滿足兩項診斷標準，以及至少六個月對社會或職業功能有顯著影響，才能診斷求診者患有精神分裂症。若要診斷成患有精神分裂症，必須具有以下症狀中的其中一項：妄想、幻覺或言语散乱。其他用以作診斷的症狀包括陰性症狀、緊張性行為或行為紊亂<ref name="DSM5pgxx">{{cite book| author= American Psychiatric Association |title= Diagnostic and Statistical Manual of Mental Disorders |publisher= American Psychiatric Publishing |location= Arlington |isbn= 978-0890425558 |pages=  |edition=5th}}</ref>。定義基本上與2000年的精神疾病診斷與統計手冊（DSM-IV-TR）相同，但是第五版做出了許多改變。

* 亞型分類——如[[偏狂型精神分裂症|偏執型]]或緊張型精神分裂症等，都遭到去除。這些在以前的修訂中得以保留的原因是基於慣例，但後來經事實證明，亞型在疾病的治療上是沒有價值的。<ref name=tandon/>
* [[紧张性抑郁障碍|僵直症]]不再與精神分裂症密切相關<ref name=cataonia-dsm>As referenced from PMID 23800613, {{cite journal |author1=Heckers S |author2=Tandon R |author3=Bustillo J |title=Catatonia in the DSM--shall we move or not? |journal=Schizophr Bull |volume=36 |issue=2 |pages=205–7 |date=2010-03  |pmid=19933711 |pmc=2833126 |doi=10.1093/schbul/sbp136 |type=Editorial}}</ref>。
* 在對精神分裂症患者的病程進行描述時，建議更好地區分病症的當前狀態及其過去發展，令整體描述更為清楚<ref name=tandon/>。
* 不再建議對{{link-en|施耐德主要症狀|Schneider's first-rank symptoms}}（Schneider's first-rank symptoms）進行特殊治療<ref name=tandon/>。
* 為了更明確地把分裂情感性障礙與精神分裂症劃分，故完善了[[分裂情感性障碍|分裂情感性障礙]]的定義<ref name=tandon>{{cite journal  |vauthors=Tandon R, Gaebel W, Barch DM, etal |title=Definition and description of schizophrenia in the DSM-5 |journal=Schizophr. Res. |volume=150 |issue=1 |pages=3–10 |date=2013-10  |pmid=23800613 |doi=10.1016/j.schres.2013.05.028}}</ref>。
* 它向医護人員推薦了一項涵蓋精神病理學八個領域的評估，用以幫助臨床決策<ref name=dimensions>{{cite journal  |vauthors=Barch DM, Bustillo J, Gaebel W, etal |title=Logic and justification for dimensional assessment of symptoms and related clinical phenomena in psychosis: relevance to DSM-5 |journal=Schizophr. Res. |volume=150 |issue=1 |pages=15–20 |date=2013-10  |pmid=23706415 |doi=10.1016/j.schres.2013.04.027 }}</ref>。

在歐洲國家，ICD-10的診斷標準較為常用；在美國和世界各地，DSM的診斷標準則較ICD-10的常用，並廣泛應用於研究中。ICD-10的診斷標準更為重視施耐德主要症狀。在醫學實踐中，兩套系統之間的一致性很高。<ref name="Jakobsen_et_al_2005">{{cite journal  |vauthors=Jakobsen KD, Frederiksen JN, Hansen T, etal |year=2005 |title=Reliability of clinical ICD-10 schizophrenia diagnoses |journal=Nordic Journal of Psychiatry |volume=59 | issue=3 |pages=209–12 |pmid=16195122 | doi = 10.1080/08039480510027698}}</ref>目前正在草擬中的ICD-11，提倡在關於精神分裂症的診斷標準中添加「自體疾患」（self-disorder）這一種症狀<ref name="Heinz_2016" />。

如果困擾患者的症狀存在超過一個月，但少於六個月，則應診斷為{{link-en|類精神分裂症|Schizophreniform disorder}}。若精神症狀持續不到一個月，則可能診斷為短暫精神病，患者所擁有的各種症狀則可歸類為[[思覺失調|未特指的精神分裂症]]。如果[[情感障礙|情感性症狀]]與分裂症狀併存，則會診斷為[[分裂情感性障碍|分裂情感性障礙]]。如果精神上的症狀是一般醫學病症或物質所直接導致的，則診斷為繼發性精神障礙。<ref name="DSM5pgxx"/>如果求診者出現[[廣泛性發展障礙|廣泛性發展障礙]]的症狀，則不能診斷為精神分裂症，除非求診者還明顯地出現了妄想或幻覺等症狀<ref name="DSM5pgxx"/>。

=== 亚型 ===
DSM-5已删去DSM-IV中提出的所有亚型<ref>American Psychiatric Association DSM-5 Work Groups (2010) [http://www.dsm5.org/ProposedRevisions/Pages/SchizophreniaandOtherPsychoticDisorders.aspx Proposed Revisions – Schizophrenia and Other Psychotic Disorders]. Retrieved 17 February 2010.</ref>。DSM-IV-TR中所包含的五個亚型如下<ref name=WHOICD/><ref>{{cite web|title=DSM-5 Changes: Schizophrenia & Psychotic Disorders |url=http://pro.psychcentral.com/dsm-5-changes-schizophrenia-psychotic-disorders/004336.html |accessdate=2016-01-08 |date=2014-05-29 |deadurl=no |archiveurl=https://web.archive.org/web/20160501001901/http://pro.psychcentral.com/dsm-5-changes-schizophrenia-psychotic-disorders/004336.html |archivedate=2016-05-01 }}</ref>：
* [[偏狂型精神分裂症|偏執型]]：又稱妄想型，患者出現妄想和幻覺，但是沒有出現思維障礙、行為紊亂或是情感淡漠。妄想的主題是也許是把事物誇張化，亦有可能令患者感到受迫害。（DSM代碼：295.3/ICD代碼：F20.0）

* {{link-en|紊乱型|Disorganized schizophrenia}}：在ICD中称作青春型，症狀既有思维障碍，亦有情感淡漠，嚴重時可出現無法閱讀文章，觀看電影電視的情況。認知能力雖然在服藥後會得到改善，但與患病前不可同日而語。認知能力損害是對患者影響最大的症狀。（DSM代碼：295.1/ICD代碼：F20.1）

* [[紧张性抑郁障碍|紧张型]]：患者几乎僵直不动或者过于兴奋，漫無目的地行动，以及脸部表情和躯体动作异常，症状还包括紧张型木僵或蠟狀屈曲（waxy flexibility）、模仿别人说话及动作等。（DSM代碼：295.2/ICD代碼：F20.2）

* 未分型：存在精神症状，但是不符合上面几种分类（DSM代碼：295.9/ICD代碼：F20.3）

* 残余型：陽性症狀僅以輕度的形式存在（DSM代碼：295.6/ICD代碼：F20.5）

ICD-10中所包含的亚型<ref name=WHOICD>{{cite web|url=http://www.who.int/classifications/icd/en/GRNBOOK.pdf |title=The ICD-10 Classification of Mental and Behavioural Disorders |format=PDF |publisher=World Health Organization |page=26 |deadurl=no |archiveurl=https://web.archive.org/web/20160618131606/http://www.who.int/classifications/icd/en/GRNBOOK.pdf |archivedate=2016-06-18 }}</ref>：

* 精神分裂症後抑鬱症：精神分裂症發病以後所出現的抑鬱發作，當中仍存有輕度精神分裂症的症狀。（ICD代碼：F20.4）

* [[单纯型精神分裂症|单纯型]]：陰性症狀隐匿地持續發展，在此以前沒有精神病發作史。（ICD代碼：F20.6）

俄羅斯版的ICD-10中亦包含了{{link-en|呆滞型精神分裂症|Sluggish schizophrenia}}，而其屬於ICD-10第5章F21節——「分裂型」障礙這一索引欄目中<ref>{{vcite web |title=МКБ-10: Классификация психических и поведенческих расстройств. F21 Шизотипическое расстройство |trans_title=The ICD-10 Classification of Mental and Behavioural Disorders. F21 Schizotypal Disorder |url=http://www.talagi.ru/library/mkb10_f2.htm#f21 |language=Russian |harvid=Russian adapted version of the ICD-10 |deadurl=yes |archiveurl=https://web.archive.org/web/20160422045836/http://www.talagi.ru/library/mkb10_f2.htm#f21 |archivedate=2016-04-22 }}</ref>。

===鑑別診斷===
幾種不同的精神障礙的患者之中亦有可能出現跟精神分裂症患者類似的心理症狀，包括[[边缘性人格障碍|边缘性人格障碍]]<ref>{{cite journal |author=Pope HG |year=1983 |title=Distinguishing bipolar disorder from schizophrenia in clinical practice: guidelines and case reports |journal=Hospital and Community Psychiatry |volume=34 |pages=322–28 |pmid=6840720 |doi=10.1176/ps.34.4.322}}</ref>、[[躁鬱症|躁鬱症]]<ref>{{cite journal |author=McGlashan TH |title=Testing DSM-III symptom criteria for schizotypal and borderline personality disorders |journal=Archives of General Psychiatry |volume=44 |issue=2 |pages=143–8 |date=1987-02  |pmid=3813809 |doi=10.1001/archpsyc.1987.01800140045007}}</ref>、{{link-en|物質誘發的精神病性疾患|Substance-induced psychosis}}、藥物中毒。[[妄想症|妄想症]]、[[迴避性人格障礙|迴避性人格障礙]]、[[類精神分裂型人格違常|類精神分裂型人格違常]]、[[社交恐懼症|社交恐懼症]]的社會退縮等，亦會令該病的患者出現「妄想」這一種症狀（非怪异妄想）。類精神分裂型人格違常的症狀與精神分裂症類似，但相對而言不太嚴重<ref name=DSM5pg101/>。雖然精神分裂症患者伴發[[強迫症|強迫症]]的常見程度遠高於可用「巧合」來解釋，但難以區分強迫症中所出現的強迫觀念和精神分裂症中所出現的妄想<ref>{{cite journal|author=Bottas A |title=Comorbidity: Schizophrenia With Obsessive-Compulsive Disorder |journal=Psychiatric Times |volume=26 |issue=4 |date=2009-04-15 |url=http://www.psychiatrictimes.com/display/article/10168/1402540 |deadurl=no |archiveurl=https://web.archive.org/web/20130403064649/http://www.psychiatrictimes.com/display/article/10168/1402540 |archivedate=2013-04-03 }}</ref>。一些人不再服用[[苯二氮䓬类|苯二氮卓類藥物]]後，會出現可持續一段長時間的嚴重戒斷症狀。戒斷症狀類似於精神分裂症，故有可能因此而誤診<ref name="gabbards">{{cite book | author=Gabbard GO | title = Gabbard's Treatments of Psychiatric Disorders, Fourth Edition (Treatments of Psychiatric Disorders) | date =  2007-05-15 | publisher = American Psychiatric Publishing | url=https://books.google.com/?id=-T2aEqfwLW4C&pg=PA209 | isbn = 1-58562-216-8 | pages = 209–11 }}</ref>。

可能需要進行更全面的醫學和神經學檢查，以排除求診者患上跟精神分裂症的臨床表現差異不大的疾病，如[[代謝疾病|代謝疾病]]、{{link-en|全身性感染|Systemic disease}}、[[梅毒|梅毒]]、[[人類免疫缺陷病毒|人類免疫缺陷病毒]]感染、[[癫痫|癫痫]]、{{link-en|邊緣性腦炎|Limbic encephalitis}}、大腦損傷。[[中風|中風]]、[[多发性硬化症|多发性硬化症]]、[[甲状腺功能亢进症|甲状腺功能亢进症]]、[[甲狀腺機能低下症|甲狀腺機能低下症]]以及像[[阿兹海默病|阿兹海默病]]、[[亨丁頓舞蹈症|亨丁頓舞蹈症]]、{{link-en|額顳癡呆|Frontotemporal dementia}}、[[路易氏體失智症|路易氏體失智症]]般的失智症的表現皆可能类以于精神分裂症。<ref>{{cite book|title=Bradley's neurology in clinical practice|year=2012|publisher=Elsevier/Saunders|location=Philadelphia, PA|isbn=1-4377-0434-4|author1=Murray ED |author2=Buttner N |author3=Price BH |volume=1|edition=6th|pages=92–111|editor1=Bradley WG |editor2=Daroff RB |editor3=Fenichel GM |editor4=Jankovic J |chapter=Depression and Psychosis in Neurological Practice}}</ref>可能有必要排除求診者出現[[譫妄|譫妄]]，其可通過幻視、急性發作以及知覺水平波動這些特點與精神分裂症區分，亦能把它視為求診者患上其他潛在性疾病的跡象。除非精神分裂症患者有特殊的醫學徵兆或可能對[[抗精神病药|抗精神病藥物]]存有[[不良反应_(医学)|不良反應]]，否則通常不會復發。對處於兒童階段的求診者而言，專業人員必須把典型的童年幻想跟幻覺分開看待。<ref name=DSM5pg101/>

==預防==
精神分裂症是難以預防的，因為沒有可靠的跡象可用於鑑定病發的後期階段<ref name="Cannon_et_al_2007">{{cite journal |author1=Cannon TD |author2=Cornblatt B |author3=McGorry P |title=The empirical status of the ultra high-risk (prodromal) research paradigm |journal=Schizophrenia Bulletin |volume=33 |issue=3 |pages=661–4 |date=2007-05  |pmid=17470445 |doi=10.1093/schbul/sbm031 |pmc=2526144}}</ref> 。已有初步證據指出早期介入對預防精神分裂症是有效果的<ref>{{cite journal|author1=Marshall M |author2=Rathbone J |title=Early intervention for psychosis|journal=The Cochrane database of systematic reviews|date=2011-06-15|issue=6|pages=CD004718|pmid=21678345|doi=10.1002/14651858.CD004718.pub3|pmc=4163966}}</ref>。雖然有一些證據指出，對[[思覺失調|精神性發作]]患者實施早期介入可能會有短期的影響，但五年後這些介入幾乎沒有對患者産生任何益處<ref name=Lancet09/>。試圖在前驅期就嘗試預防精神分裂症的益處並不確定，因此截至2009年為止也不推薦施行<ref>{{cite journal  |vauthors=de Koning MB, Bloemen OJ, van Amelsvoort TA, etal |title=Early intervention in patients at ultra high risk of psychosis: benefits and risks |journal=Acta Psychiatr Scand |volume=119 |issue=6 |pages=426–42 |date= 2009-06  |pmid=19392813 |doi=10.1111/j.1600-0447.2009.01372.x |url=}}</ref>。實施[[认知行为疗法|认知行为疗法]]一年後，可能會降低高風險人士患上精神病的風險<ref>{{cite journal|author1=Stafford MR |author2=Jackson H |author3=Mayo-Wilson E |author4=Morrison AP |author5=Kendall T |title=Early interventions to prevent psychosis: systematic review and meta-analysis|journal=BMJ (Clinical research ed.)|date=2013-01-18|volume=346|pages=f185|pmid=23335473|pmc=3548617|doi=10.1136/bmj.f185}}</ref>，故此{{link-en|英國國家健康與照顧卓越研究院|National Institute for Health and Care Excellence}}推薦在高風險人士中實施該種療法<ref>{{cite web|title=Psychosis and schizophrenia in adults: treatment and management |url=http://www.nice.org.uk/nicemedia/live/14382/66534/66534.pdf |work=NICE |accessdate=2014-04-19 |page=7 |date=2014-03 |deadurl=yes |archiveurl=https://web.archive.org/web/20140420070946/http://www.nice.org.uk/nicemedia/live/14382/66534/66534.pdf |archivedate=2014-04-20 }}</ref>。另一項預防措施是避免接觸與發病相關的藥物，包括[[大麻_(藥用)|大麻]]、[[可卡因|可卡因]]和[[安非他命|安非他命]]<ref name=BMJ07/>。

==病情管理==
精神分裂症的治療重心是為患者處方[[抗精神病藥物|抗精神病藥物]]，一般会在此基礎上配合心理及社會支援輔導<ref name=Lancet09/>。當患者嚴重發作時，可能會{{link-en|自願地|Voluntary commitment}}或[[預防性拘留|強制性地]]住院（如果當地的精神衛生相關法律條文允許強制住院）。長期住院在現在而言是十分罕見的，因為醫療體系從50年代開始{{link-en|去機構化|Deinstitutionalisation}}（Deinstitutionalisation），但長期住院的情況現今仍會發生<ref name="BeckerKilian2006" />。社區支援服務包括入住康復中心、{{link-en|社區心理健康團隊|Community mental health service}}的成員訪問、就業能力復康訓練<ref>{{cite journal |author1=McGurk SR |author2=Mueser KT |author3=Feldman K |author4=Wolfe R |author5=Pascaris A | title = Cognitive training for supported employment: 2–3 year outcomes of a randomized controlled trial. | journal = American Journal of Psychiatry | volume = 164 | issue = 3 | pages = 437–41 |date=2007-03 | url = http://ajp.psychiatryonline.org/cgi/content/full/164/3/437 | doi = 10.1176/appi.ajp.164.3.437 | pmid = 17329468 }}</ref> 。一些證據表明，定期運動對精神分裂症患者的身體和精神健康有一定幫助<ref>{{cite journal |author1=Gorczynski P |author2=Faulkner G |title=Exercise therapy for schizophrenia |journal=Cochrane Database of Systematic Reviews |issue=5 |pages=CD004412 |year=2010 |pmid=20464730 |doi=10.1002/14651858.CD004412.pub2 |url=}}</ref>。截至2015年，{{link-en|穿顱磁刺激|transcranial magnetic stimulation}}對精神分裂症的治療效果尚不明確<ref>{{cite journal |last1=Dougall |first1=N |last2=Maayan |first2=N |last3=Soares-Weiser |first3=K |last4=McDermott |first4=LM |last5=McIntosh |first5=A |title=Transcranial magnetic stimulation (TMS) for schizophrenia. |journal=The Cochrane Database of Systematic Reviews |date=2015-08-20 |issue=8 |pages=CD006081 |doi=10.1002/14651858.CD006081.pub2 |pmid=26289586}}</ref>。
===藥物治療===
[[File:Risperdal_tablets.jpg|thumb]]是一種常見的[[抗精神病藥物|抗精神病藥物]]。]]
精神分裂症的一線治療是為患者處方[[抗精神病藥物|抗精神病藥物]]<ref name="fn_72"/>，其可在約7至14天內把陽性症狀的程度減輕<ref name="fn_72">{{cite web|url=http://www.nice.org.uk/nicemedia/pdf/CG82FullGuideline.pdf |title=Schizophrenia: Full national clinical guideline on core interventions in primary and secondary care |accessdate=2009-11-25 |author=National Collaborating Centre for Mental Health |date=2009-03-25 |deadurl=yes |archiveurl=https://web.archive.org/web/20130512190108/http://www.nice.org.uk/nicemedia/pdf/CG82FullGuideline.pdf |archivedate=2013-05-12 }}</ref>。然而，抗精神病藥物對陰性症狀和認知功能障礙的改善效果並不顯著<ref name=AFP10/><ref name="pmid18291627">{{cite journal |author1=Tandon R |author2=Keshavan MS |author3=Nasrallah HA |title=Schizophrenia, "Just the Facts": what we know in 2008 part 1: overview |journal=Schizophrenia Research |volume=100 |issue=1–3 |pages=4–19 |date=2008-03  |pmid=18291627 |doi=10.1016/j.schres.2008.01.022 |url=http://download.journals.elsevierhealth.com/pdfs/journals/0920-9964/PIIS0920996408000716.pdf}}</ref>。若患者持續实行藥物治療，便可降低復發的風險<ref name=Relapse2012>{{cite journal  |vauthors=Leucht S, Tardy M, Komossa K, etal |title=Antipsychotic drugs versus placebo for relapse prevention in schizophrenia: a systematic review and meta-analysis |journal=Lancet |volume=379 |issue=9831 |pages=2063–71 |date=2012-06  |pmid=22560607 |doi=10.1016/S0140-6736(12)60239-6 }}</ref><ref name=Harrow2013>{{cite journal|author1=Harrow M |author2=Jobe TH |title=Does long-term treatment of schizophrenia with antipsychotic medications facilitate recovery?|journal=Schizophrenia bulletin|date=2013-03-19|pmid=23512950|volume=39|issue=5|pages=962–5|doi=10.1093/schbul/sbt034|pmc=3756791}}</ref>。極少證據顯示他們实行藥物治療超過兩三年後的效果会怎樣<ref name=Harrow2013/>。然而抗精神病藥物可導致患者對多巴胺過敏，增加患者一旦停藥後出現症狀的機會<ref>{{cite journal | vauthors = Seeman MV, Seeman P | title = Is schizophrenia a dopamine supersensitivity psychotic reaction? | journal = Progress in Neuro-Psychopharmacology & Biological Psychiatry | volume = 48 | pages = 155–60 | date = January 2014 | pmid = 24128684 | pmc = 3858317 | doi = 10.1016/j.pnpbp.2013.10.003 }}</ref>。

選用抗精神病藥物时應考慮它的成效、風險和成本<ref name=Lancet09/>。典型和非典型抗精神病藥物之間那種的效果較佳這點至今仍有爭議<ref name=Kane2010/><ref>{{cite journal  |vauthors=Hartling L, Abou-Setta AM, Dursun S, etal |title=Antipsychotics in Adults With Schizophrenia: Comparative Effectiveness of First-generation versus second-generation medications: a systematic review and meta-analysis |journal=Annals of Internal Medicine|date=2012-08-14|pmid=22893011|doi=10.7326/0003-4819-157-7-201210020-00525 |volume=157 |issue=7 |pages=498–511}}</ref>。[[氨磺必利|氨磺必利]]（Amisulpride）、[[奥氮平|奥氮平]]（Olanzapine）、[[維思通|維思通]]（Risperidone）、[[氯氮平|氯氮平]]的效果可能會較佳，但這些藥物也與較大的副作用相關<ref name="barry 2012">{{cite journal |author1=Barry SJE |author2=Gaughan TM |author3=Hunter R |year=2012 |title=Schizophrenia |journal=BMJ Clinical Evidence |pmid=23870705 |url=http://www.clinicalevidence.bmj.com/x/systematic-review/1007/archive/06/2012.html |volume=2012 |pmc=3385413 |deadurl=yes |archiveurl=https://archive.is/20140911114812/http://www.clinicalevidence.bmj.com/x/systematic-review/1007/archive/06/2012.html |archivedate=2014-09-11 }}</ref>。當以低至中等的劑量使用典型抗精神病藥物時，其症狀復發率和中途放弃率會與非典型抗精神病藥物相同<ref name=AFP07>{{cite journal |author1=Schultz SH |author2=North SW |author3=Shields CG |title=Schizophrenia: a review |journal=Am Fam Physician |volume=75 |issue=12 |pages=1821–9 |date=2007-06  |pmid=17619525}}</ref>。40-50％的個案對藥物治療的反應良好，30-40％的個案在藥物治療後症狀部分緩解，治療抵抗的則有20％（在服用2-3種不同的抗精神病藥六週後症狀仍没得到令人滿意的改善）<ref name=AFP10/>。氯氮平能有效治療對其他藥物反應差的個案（治療抵抗性精神分裂症或难治性精神分裂症）<ref>{{cite journal |author=Taylor DM |title=Refractory schizophrenia and atypical antipsychotics |journal=J Psychopharmacol |volume= 14|issue=4 |pages=409–418 |year=2000 |doi=10.1177/026988110001400411 |pmid=11198061}}</ref>。但它在不到4％的人中會導致一種嚴重的可能副作用——{{link-en|粒細胞缺乏症|Agranulocytosis}}（低[[白细胞|白细胞]]计数）<ref name=BMJ07/><ref name=Lancet09/><ref>{{cite journal |author1=Essali A |author2=Al-Haj Haasan N |author3=Li C |author4=Rathbone J |title=Clozapine versus typical neuroleptic medication for schizophrenia |journal=Cochrane Database of Systematic Reviews |volume= |issue=1 |pages=CD000059 |year=2009 |pmid=19160174 |doi=10.1002/14651858.CD000059.pub2 }}</ref>。

大多數接受藥物治療的患者都會受到藥物的副作用所影響。服用典型抗精神病藥物的患者擁有更高的比率出現一種由藥物引發的副作用——[[錐體外症候群|錐體外症候群]]，而一些非典型抗精神病藥物與體重大幅增加，患上糖尿病及[[代謝症候群|代謝症候群]]的風險上升相關；這在服用奧氮平的情況下最為明顯，利培酮和喹硫平則與體重增加相關<ref name="barry 2012"/>。利培酮與氟哌啶醇這兩種藥物引起錐體外症候群的比率類似<ref name="barry 2012"/>。目前尚不清楚新一代的抗精神病藥物能否降低誘發{{link-en|抗精神藥物惡性症候群|Neuroleptic malignant syndrome}}或{{link-en|遲發性運動障礙|tardive dyskinesia}}（罕見但嚴重的神經性障礙）的機會<ref name="Ananth_et_al_2004">{{cite journal |author1=Ananth J |author2=Parameswaran S |author3=Gunatilake S |author4=Burgoyne K |author5=Sidhom T |title=Neuroleptic malignant syndrome and atypical antipsychotic drugs |journal=Journal of Clinical Psychiatry |volume=65 |issue=4 |pages=464–70 |date=2004-04  |pmid=15119907 |doi=10.4088/JCP.v65n0403}}</ref>。

針對不願意或不能定期服用藥物的患者，可以使用長效抗精神病藥物控制病情<ref name=Depo06>{{cite journal |author=McEvoy JP |title=Risks versus benefits of different types of long-acting injectable antipsychotics |journal=J Clin Psychiatry |volume=67 Suppl 5 |issue= |pages=15–8 |year=2006 |pmid=16822092}}</ref>。與口服藥物相比，長效抗精神病藥物能以更大的程度去降低復發的風險<ref name=Relapse2012/>。當與心理社會一同介入時，它們可能會改善患者對治療的長期依從性<ref name=Depo06/>。[[美國精神醫學學會|美國精神醫學學會]]建議，若患者一年以上没出現任何與精神分裂症有關的症狀，則可考慮停藥<ref name=Harrow2013>{{cite journal|author1=Harrow M |author2=Jobe TH |title=Does long-term treatment of schizophrenia with antipsychotic medications facilitate recovery?|journal=Schizophrenia bulletin|date=2013-03-19|pmid=23512950|volume=39|issue=5|pages=962–5|doi=10.1093/schbul/sbt034|pmc=3756791}}</ref>。

=== 社會心理治療 ===
許多社會心理介入手段可能有助於治療精神分裂症，包括{{link-en|家庭治療|Family therapy}}<ref name=FT10>{{cite journal |author1=Pharoah F |author2=Mari J |author3=Rathbone J |author4=Wong W |title=Family intervention for schizophrenia |journal=Cochrane Database of Systematic Reviews |volume=12 |pages=CD000088 |year=2010 |pmid=21154340 |doi=10.1002/14651858.CD000088.pub3 |issue=12}}</ref>、{{link-en|積極性社區治療|Assertive community treatment}}、就業協助、{{link-en|認知矯正治療|Cognitive remediation therapy}}<ref name="Medalia-2009">{{cite journal|author1=Medalia A |author2=Choi J |title=Cognitive remediation in schizophrenia. |journal=Neuropsychology Rev |url=http://www.brown.uk.com/schizophrenia/medalia.pdf |volume=19 |issue=3 |pages=353–364 |year=2009 |doi=10.1007/s11065-009-9097-y |pmid=19444614 |deadurl=no |archiveurl=https://web.archive.org/web/20161023084359/http://www.brown.uk.com/schizophrenia/medalia.pdf |archivedate=2016-10-23 }}</ref>、技能培訓、 代幣制治療，以及針對物質使用和體重管理的社會心理介入<ref name=PORT09>{{cite journal  |vauthors=Dixon LB, Dickerson F, Bellack AS, etal |title=The 2009 schizophrenia PORT psychosocial treatment recommendations and summary statements |journal=Schizophr Bull |volume=36 |issue=1 |pages=48–70 |date=2010-01  |pmid=19955389 |doi=10.1093/schbul/sbp115 |pmc=2800143}}</ref>。家庭治療或教育能解決患者的家庭問題，這樣可能會減少患者復發和住院的機會<ref name=FT10/>。极少證據顯示認知行為治療（CBT）在預防復發或減輕復發的症狀這方面是有效的<ref>{{cite journal |vauthors=Jauhar S, McKenna PJ, Radua J, etal |title=Cognitive-behavioural therapy for the symptoms of schizophrenia: systematic review and meta-analysis with examination of potential bias|journal=The British Journal of Psychiatry|date=2014-01|volume=204|pages=20–9|pmid=24385461|type=Review|doi=10.1192/bjp.bp.112.116285|issue=1}}</ref><ref>{{cite journal |author1=Jones C |author2=Hacker D |author3=Cormac I |author4=Meaden A |author5=Irving CB |title=Cognitive behaviour therapy versus other psychosocial treatments for schizophrenia |journal=Cochrane Database of Systematic Reviews |volume= 4|issue=4 |pages=CD008712 |year=2012 |pmid=22513966 |doi=10.1002/14651858.CD008712.pub2}}</ref>。後設認知訓練的證據結果不一，一些綜述的結論認為其能產生益處，一些则認為不能<ref>{{cite journal | vauthors = Eichner C, Berna F | title = Acceptance and Efficacy of Metacognitive Training (MCT) on Positive Symptoms and Delusions in Patients With Schizophrenia: A Meta-analysis Taking Into Account Important Moderators | journal = Schizophrenia Bulletin | volume = 42 | issue = 4 | pages = 952–62 | date = July 2016 | pmid = 26748396 | pmc = 4903058 | doi = 10.1093/schbul/sbv225 }}</ref><ref>{{cite journal | vauthors = van Oosterhout B, Smit F, Krabbendam L, Castelein S, Staring AB, van der Gaag M | title = Metacognitive training for schizophrenia spectrum patients: a meta-analysis on outcome studies | journal = Psychological Medicine | volume = 46 | issue = 1 | pages = 47–57 | date = January 2016 | pmid = 26190517 | doi = 10.1017/s0033291715001105 }}</ref><ref>{{cite journal |last1=Liu |first1=YC |last2=Tang |first2=CC |last3=Hung |first3=TT |last4=Tsai |first4=PC |last5=Lin |first5=MF |title=The Efficacy of Metacognitive Training for Delusions in Patients With Schizophrenia: A Meta-Analysis of Randomized Controlled Trials Informs Evidence-Based Practice. |journal=Worldviews on evidence-based nursing |date=April 2018 |volume=15 |issue=2 |pages=130–139 |doi=10.1111/wvn.12282 |pmid=29489070}}</ref>。沒有較佳質量的研究支持藝術或戲劇治療的有效性<ref>{{cite journal|author1=Ruddy R |author2=Milnes D |title=Art therapy for schizophrenia or schizophrenia-like illnesses. |journal=Cochrane Database of Systematic Reviews |issue=4 |pages=CD003728 |url=http://www.cochrane.org/reviews/en/ab003728.html |year=2005 |doi=10.1002/14651858.CD003728.pub2 |pmid=16235338 |deadurl=no |archiveurl=https://web.archive.org/web/20111027132811/http://www2.cochrane.org/reviews/en/ab003728.html |archivedate=2011-10-27 }}</ref><ref name="Ruddy-2007">{{cite journal|author1=Ruddy RA |author2=Dent-Brown K |title=Drama therapy for schizophrenia or schizophrenia-like illnesses. |journal=Cochrane Database of Systematic Reviews |url=http://www.cochrane.org/reviews/en/ab005378.html |issue=1 |pages=CD005378 |year=2007 |doi=10.1002/14651858.CD005378.pub2 |pmid=17253555 |deadurl=no |archiveurl=https://web.archive.org/web/20110825024045/http://www2.cochrane.org/reviews/en/ab005378.html |archivedate=2011-08-25 }}</ref>。當與正常治療配合時，音樂療法能改善精神狀態和社會功能<ref>{{cite journal|last1=Mössler|first1=K|last2=Chen|first2=X|last3=Heldal|first3=TO|last4=Gold|first4=C|title=Music therapy for people with schizophrenia and schizophrenia-like disorders.|journal=The Cochrane database of systematic reviews|date=2011-12-07|issue=12|pages=CD004025|pmid=22161383|doi=10.1002/14651858.CD004025.pub3}}</ref>。

==預後==
[[File:Schizophrenia_world_map_-_DALY_-_WHO2004.svg|thumb]]估量全球各國因精神分裂症造成的負擔（2004年，數值以每100,000居民為單位）
{{Multicol}}
{{legend|#b3b3b3|無數據}}
{{legend|#ffff65|≤ 185}}
{{legend|#fff200|185–197}}
{{legend|#ffdc00|197–207}}
{{legend|#ffc600|207–218}}
{{legend|#ffb000|218–229}}
{{legend|#ff9a00|229–240}}
{{Multicol-break}}
{{legend|#ff8400|240–251}}
{{legend|#ff6e00|251–262}}
{{legend|#ff5800|262–273}}
{{legend|#ff4200|273–284}}
{{legend|#ff2c00|284–295}}
{{legend|#cb0000|≥ 295}}
{{Multicol-end}}]]
精神分裂症花費了龐大的人力和經濟成本<ref name=Lancet09/>。它會使患者的預期壽命降低10-25年<ref name=Lauren2012/>。這主要是因為它與[[肥胖|肥胖]]、飲食不良、[[坐式生活型態|坐式生活型態]]以及[[吸煙|吸煙]]有關，[[自殺|自殺]]率的增加亦起了較小的作用<ref name=Lancet09/><ref name=Lauren2012/><ref>{{cite journal|author1=Erlangsen A |author2=Eaton WW |author3=Mortensen PB |author4=Conwell Y |title=Schizophrenia--a predictor of suicide during the second half of life?|journal=Schizophrenia Research|date=2012-02|volume=134|issue=2-3|pages=111–7|pmid=22018943|doi=10.1016/j.schres.2011.09.032}}</ref> 。抗精神病藥物也可能增加預期壽命降低的風險<ref name=Lauren2012/>。患者的預期壽命在20世紀70年代至90年代間增加<ref name=Mort07>{{cite journal |author1=Saha S |author2=Chant D |author3=McGrath J |title=A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? |journal=Arch. Gen. Psychiatry |volume=64 |issue=10 |pages=1123–31 |date=2007-10  |pmid=17909124 |doi=10.1001/archpsyc.64.10.1123}}</ref>。

精神分裂症是[[身心障礙|身心障礙]]的主要原因之一，精神病是排在{{link-en|四肢癱瘓|Tetraplegia}}和[[失智症|失智症]]之後第三常見的身心障礙，並比{{link-en|截癱|Paraplegia}}和[[失明|失明]]常見<ref name="fn_35">{{cite journal |vauthors=Ustün TB, Rehm J, Chatterji S, Saxena S, Trotter R, Room R, Bickenbach J  |year=1999 |title=Multiple-informant ranking of the disabling effects of different health conditions in 14 countries |journal=[[The_Lancet|The Lancet]] |volume=354 | issue=9173 |pages=111–15 |pmid=10408486 |doi=10.1016/S0140-6736(98)07507-2}}</ref>。大約四分之三的精神分裂症患者伴有其他持續性復發的身心障礙<ref name=AFP10>{{cite journal |author1=Smith T |author2=Weston C |author3=Lieberman J |title=Schizophrenia (maintenance treatment) |journal=Am Fam Physician |volume=82 |issue=4 |pages=338–9 |date=2010-08  |pmid=20704164 }}</ref>。全球有1670萬名患者被認為患有中度或重度的身心障礙<ref>{{cite book|author=World Health Organization|title=The global burden of disease : 2004 update |year=2008|publisher=World Health Organization|location=Geneva, Switzerland|isbn=9789241563710|pages=35|edition=[Online-Ausg.]}}</ref>。有些患者能完全康復及使其他社會功能維持良好狀態<ref>{{cite journal |author=Warner R |title=Recovery from schizophrenia and the recovery model |journal=Current Opinion in Psychiatry |volume=22 |issue=4 |pages=374–80 |date=2009-07  |pmid=19417668 |doi=10.1097/YCO.0b013e32832c920b |url=}}</ref>。大多數精神分裂症患者在社區支持下獨立生活<ref name=Lancet09/>。約85％的患者失業<ref name=Lancet2016/>。在第一次精神病發作的人中，42％的患者有良好的長期預後結果；預後結果一般的有35％；預後結果不佳的則有27％<ref>{{cite journal |author1=Menezes NM |author2=Arenovich T |author3=Zipursky RB |title=A systematic review of longitudinal outcome studies of first-episode psychosis |journal=Psychol Med |volume=36 |issue=10 |pages=1349–62 |date=2006-10  |pmid=16756689 |doi=10.1017/S0033291706007951 |url=}}</ref>。有研究顯示[[發展中國家|發展中國家]]的預後結果會比[[發達國家|發達國家]]更好<ref name=Isa07>{{cite journal |author1=Isaac M |author2=Chand P |author3=Murthy P |title=Schizophrenia outcome measures in the wider international community |journal=Br J Psychiatry Suppl |volume=50 |issue= |pages=s71–7 |date=2007-08  |pmid=18019048 |doi=10.1192/bjp.191.50.s71}}</ref>，但這項結論備受質疑<ref>{{cite journal |author1=Cohen A |author2=Patel V |author3=Thara R |author4=Gureje O |title=Questioning an axiom: better prognosis for schizophrenia in the developing world? |journal=Schizophr Bull |volume=34 |issue=2 |pages=229–44 |date=2008-03  |pmid=17905787 |pmc=2632419 |doi=10.1093/schbul/sbm105}}</ref><ref>{{cite journal |author=Burns J |title=Dispelling a myth: developing world poverty, inequality, violence and social fragmentation are not good for outcome in schizophrenia |journal=Afr J Psychiatry (Johannesbg) |volume=12 |issue=3 |pages=200–5 |date=2009-08  |pmid=19894340 |doi=10.4314/ajpsy.v12i3.48494}}</ref>。

精神分裂症患者的自殺率高於平均水平。據引證為10％，但是一項較以上引證新的分析將估計值修改成4.9％，自殺最常發生在發病或首次住院後的一段時間<ref name=Jop2010/><ref>{{cite journal |author1=Palmer BA |author2=Pankratz VS |author3=Bostwick JM |title=The lifetime risk of suicide in schizophrenia: a reexamination |journal=Archives of General Psychiatry|volume=62 |issue=3 |pages=247–53 |date=2005-03  |pmid=15753237 |doi=10.1001/archpsyc.62.3.247}}</ref>。20%至40%的患者至少嘗試自殺一次<ref name=DSM5pg101/><ref name=Suicide10/>。有着各種各樣的自殺高危因子，包括患者是男性、伴發抑鬱症和擁有高[[智商|智商]]這些特點<ref name=Suicide10>{{cite journal |author1=Carlborg A |author2=Winnerbäck K |author3=Jönsson EG |author4=Jokinen J |author5=Nordström P |title=Suicide in schizophrenia |journal=Expert Rev Neurother |volume=10 |issue=7 |pages=1153–64 |date= 2010-07  |pmid=20586695 |doi=10.1586/ern.10.82 |url=}}</ref>。

全世界的研究都顯示，精神分裂症和吸煙之間擁有着強烈的關係<ref name="de Leon">{{cite journal|pmid=15949648|year=2005|author1=De Leon J |author2=Diaz FJ |title=A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors|volume=76|issue=2–3|pages=135–57|doi=10.1016/j.schres.2005.02.010|journal=Schizophrenia Research}}</ref><ref name="Keltner">{{cite journal|doi=10.1111/j.1744-6163.2006.00085.x|title=Smoke, Smoke, Smoke That Cigarette|year=2006|author1=Keltner NL |author2=Grant JS |journal=Perspectives in Psychiatric Care|volume=42|pages=256–61|pmid=17107571|issue=4}}</ref>。在診斷出精神分裂症的人中，抽煙的比例較一般人口高：普通人群中只有20％是經常抽煙者，精神分裂症患者中則估計達80％至90％<ref name="Keltner"/>。他們更傾向於大量地抽煙，以及抽具有高尼古丁含量的香煙<ref name="DSM304">American Psychiatric Association. Task Force on DSM-IV. (2000). Diagnostic and statistical manual of mental disorders: DSM-IV-TR. American Psychiatric Pub. ISBN 978-0-89042-025-6. p. 304</ref>。一些證據表明偏執型精神分裂症患者在獨立生活和職業功能上，可能比患上其他類型的精神分裂症的人更為有展望<ref name="DSM314">American Psychiatric Association. Task Force on DSM-IV. (2000). Diagnostic and statistical manual of mental disorders: DSM-IV-TR. American Psychiatric Pub. ISBN 978-0-89042-025-6. p. 314</ref>。精神分裂症患者使用[[大麻_(藥用)|大麻]]的情況亦頗為常見<ref name=Gregg2007/>。

==流行病學==
[[File:Schizophrenia world map-Deaths per million persons-WHO2012.svg|thumb|upright=1.3|各地區每百萬人中死於精神分裂症的人數（2012年）
{{refbegin|3}}{{legend|#ffff20|0-0}}{{legend|#ffc020|1-1}}{{legend|#ff9a20|2-2}}{{legend|#f08015|3-3}}{{legend|#d85010|4-6}}{{legend|#d02010|7-20}}{{refend}}]]
全世界約有0.3-0.7％人口<ref name=Lancet09/>——相當於2018年全世界超过2300万人<ref name="management Schizophrenia">{{cite web|url=http://www.who.int/mental_health/management/schizophrenia/en/ |title=Schizophrenia |publisher=World Health Organization |year=2018 |accessdate=2018-11-08 |deadurl=no |archiveurl=https://web.archive.org/web/20161108214312/http://www.who.int/mental_health/management/schizophrenia/en/ |archivedate=2016-11-08 }}</ref>——在其一生中受精神分裂症所影響。男性的發生率比女性高1.4倍，亦通常較早病發<ref name=BMJ07/>（發病的高峰年齡男性25歲，女性27歲<ref name=Cascio>{{cite journal|author1=Cascio MT |author2=Cella M |author3=Preti A |author4=Meneghelli A |author5=Cocchi A |title=Gender and duration of untreated psychosis: a systematic review and meta-analysis|journal=Early intervention in psychiatry|date=2012-05|volume=6|issue=2|pages=115–27|pmid=22380467|type= Review|doi=10.1111/j.1751-7893.2012.00351.x}}</ref>）。童年發病的患者較為罕見<ref name="Kumra_et_al_2001">{{cite journal |author1=Kumra S |author2=Shaw M |author3=Merka P |author4=Nakayama E |author5=Augustin R |year=2001 |title=Childhood-onset schizophrenia: research update |journal=Canadian Journal of Psychiatry |volume=46 | issue=10 |pages=923–30 |pmid=11816313}}</ref>，罕見的程度和中年或老年發病者相當<ref>{{cite book |veditors=Hassett A, Ames D, Chiu E | title = Psychosis in the Elderly | publisher = London: Taylor and Francis. |isbn=1-84184-394-6 | year = 2005 | page = 6 | url = https://books.google.com/?id=eLaMOJ9oj28C&printsec=frontcover&dq=Psychosis+in+the+Elderly}}</ref>。

雖然以前認為精神分裂症在世界各地的發生率差不多，但事實上其發生率在世界各地<ref name=DSM5pg101/><ref name="Jablensky_et_al_1992">{{cite journal  |vauthors=Jablensky A, Sartorius N, Ernberg G, etal |year=1992 |title=Schizophrenia: manifestations, incidence and course in different cultures. A World Health Organization ten-country study |journal=Psychological Medicine Monograph Supplement |volume=20 |pages=1–97 |pmid=1565705 |doi=10.1017/S0264180100000904}}</ref>、各國家<ref name="Kirkbride_et_al_2006">{{cite journal  |vauthors=Kirkbride JB, Fearon P, Morgan C, etal |title=Heterogeneity in incidence rates of schizophrenia and other psychotic syndromes: findings from the 3-center AeSOP study |journal=Archives of General Psychiatry |volume=63 |issue=3 |pages=250–8 |date=2006-03  |pmid=16520429 |doi=10.1001/archpsyc.63.3.250}}</ref>以及各地區<ref name="Kirkbride_et_al_2007">{{cite journal  |vauthors=Kirkbride JB, Fearon P, Morgan C, etal |year=2007 |title=Neighbourhood variation in the incidence of psychotic disorders in Southeast London |journal=Social Psychiatry and Psychiatric Epidemiology |volume=42 | issue=6 |pages=438–45 |pmid=17473901 | doi = 10.1007/s00127-007-0193-0}}</ref>都有不同。估計相差可達五倍<ref name=Lancet2016/>。全球[[失能調整生命年|失能調整生命年]]中的約1％是由它所導致<ref name="BMJ07"/>，它亦在2010年令20,000人死亡<ref name=Loz2012>{{cite journal  |vauthors=Lozano R, Naghavi M, Foreman K, etal |title=Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 |journal=Lancet |volume=380 |issue=9859 |pages=2095–128 |date=2012-12  |pmid=23245604 |doi=10.1016/S0140-6736(12)61728-0 }}</ref>。對精神分裂症的定義不同這一點，可使其發生率相差達三倍<ref name=Lancet09/>。

2000年，[[世界衛生組織|世界衛生組織]]發現，受精神分裂症影響的人口百分比和每年的新病例數在全世界大致相同。經過年齡標準化後，每10萬男性的盛行率：最低為非洲（343人），最高為大洋洲和日本（544人）；每10萬女性的盛行率：最低亦為非洲（378人），最高為東南歐（527人）<ref>{{cite web|title=Global burden of schizophrenia in the year 2000 |url=http://www.who.int/healthinfo/statistics/bod_schizophrenia.pdf |publisher=World Health Organization |author=Ayuso-Mateos JL |accessdate=2013-12-27 |deadurl=no |archiveurl=https://web.archive.org/web/20160304075113/http://www.who.int/healthinfo/statistics/bod_schizophrenia.pdf |archivedate=2016-03-04 }}</ref>。在美國，大約1.1％的成年人患有精神分裂症<ref>{{cite web|title=Schizophrenia |url=http://www.nimh.nih.gov/health/statistics/prevalence/schizophrenia.shtml |accessdate=2015-12-29 |deadurl=no |archiveurl=https://web.archive.org/web/20161004192420/https://www.nimh.nih.gov/health/statistics/prevalence/schizophrenia.shtml |archivedate=2016-10-04 }}</ref>。

== 历史 ==
[[File:Eugen_bleuler.jpg|thumb]]提出，中文名稱「精神-{}-分裂-{}-症」是由此直譯而來。]]
在20世紀初，精神病學家{{link-en|庫爾特·施奈德|Kurt Schneider}}把一些他認為能使精神分裂症與其他精神障礙區分的症狀列出。這些症狀後來稱為「首级症状」（first-rank symptoms）或「施耐德主要症狀」（Schneider's first-rank symptoms）。當中包括外源所控制的妄想、思想抽離、思想插入、思想廣播、聽見評論自己的思想或行為的幻聽，或能與幻聽溝通<ref name="SchneiderClinicalPsychopathology">{{cite book|author=Schneider K|title=Clinical Psychopathology |url=https://books.google.com/?id=ofzOAAAAMAAJ |edition=5 |year=1959 |publisher=Grune & Stratton |location=New York }}</ref>。雖然施耐德主要症狀對當前的診斷標準有很大的貢獻，但其特異性仍受到質疑。一份對1970年至2005年間進行的診斷研究回顧發現，施耐德的聲稱應不需再確認或受到反對，並且建議在未來所修訂的診斷系統中應強調施耐德主要症狀<ref name="pmid17562695">{{cite journal |author1=Nordgaard J |author2=Arnfred SM |author3=Handest P |author4=Parnas J |title=The diagnostic status of first-rank symptoms |journal=Schizophrenia Bulletin |volume=34 |issue=1 |pages=137–54 |date= 2008-01  |pmid=17562695 |pmc=2632385 |doi=10.1093/schbul/sbm044}}</ref>。缺少施耐德主要症狀的患者亦應懷疑其是否真的患上精神分裂症<ref name="Heinz_2016" />。

精神分裂症的歷史具有一定复杂性，且不容易利用線性敘事的方式展述<ref>{{cite web|author==Yuhas, Daisy |title=Throughout History, Defining Schizophrenia Has Remained a Challenge |url=http://www.scientificamerican.com/article.cfm?id=throughout-history-defining-schizophrenia-has-remained-challenge |publisher=Scientific American Mind (March/April 2013) |accessdate=2013-03-03 |deadurl=no |archiveurl=https://web.archive.org/web/20131105011048/http://www.scientificamerican.com/article.cfm?id=throughout-history-defining-schizophrenia-has-remained-challenge |archivedate=2013-11-05 }}</ref>。雖然類精神分裂症在19世紀以前的歷史記錄中是較為罕見的，但不合理、不可理解或不受控制的行為記錄則較為常見。1797年關於{{link-en|詹姆斯·蒂利·馬修斯|James Tilly Matthews}}的病例詳細報告，以及[[菲利普·皮內爾|菲利普·皮內爾]]於1809年所發表的報告，一般認為是在醫學和精神病學文獻中最早出現的精神分裂症個案。<ref name="Heinrichs2003">{{cite journal |author=Heinrichs RW |title=Historical origins of schizophrenia: two early madmen and their illness |journal=Journal of the History of the Behavioral Sciences |volume=39 |issue=4 |pages=349–63 |year=2003 |pmid=14601041 |doi=10.1002/jhbs.10152}}</ref>1886年，德國精神病學家海因里希·舒勒（Heinrich Schule）首次使用拉丁文用語「dementia praecox」（早發失智症）这一術語去稱呼現在的精神分裂症。其後{{link-en|阿諾德·皮克|Arnold Pick}}於1891年在他的精神障礙病例報告中使用了它。1893年，{{link-en|埃米爾·克雷佩林|Emil Kraepelin}}借用了皮克和舒勒所使用的術語，並於1899年在精神疾病分類中区分了早發失智症和情緒障礙（躁狂抑鬱症，包括單相性和雙相性抑鬱症）。<ref>{{cite book|author=Noll, Richard|title=American madness: the rise and fall of dementia praecox|year=2011|publisher=Harvard University Press|location=Cambridge, MA|isbn=978-0-674-04739-6}}</ref>他認為早發失智症可能是由長期系統性的疾病或全人疾病所引起的，其影響身體的許多器官和周圍神經，但其最終會於青春期後在一連串決定性的事件中影響大腦<ref>{{cite journal|author=Noll R |title=Whole body madness |journal=Psychiatric Times |year=2012 |volume=29 |issue=12 |pages=13–14 |url=http://www.psychiatrictimes.com/blog/couchincrisis/content/article/10168/2104852 |deadurl=no |archiveurl=https://web.archive.org/web/20130111095522/http://www.psychiatrictimes.com/blog/couchincrisis/content/article/10168/2104852 |archivedate=2013-01-11 }}</ref> 。他亦利用了「praecox」（早发的）这一術語去把其與其他形式的癡呆症如阿爾茨海默病作區分，阿爾茨海默病通常在年老的人身上發生<ref name="fn_49">{{cite book |author1=Hansen RA |author2=Atchison B |title=Conditions in occupational therapy: effect on occupational performance |publisher=Lippincott Williams & Wilkins |location=Hagerstown, MD |year=2000 |isbn=0-683-30417-8}}</ref>。有時大眾会認為1852年法國醫生班尼迪克·莫莱尔（Bénédict Morel）使用「démenceprécoce」這一術語可視同醫學上對精神分裂症的發現，然而，這項想法忽略了一個事實：在十九世紀末，沒有什麼可以把莫莱尔所使用的描述性術語跟早發失智症的獨立病發這一概念聯繫起來<ref name="Berriosetal2003">{{cite journal |author1=Berrios G.E. |author2=Luque R |author3=Villagran J | year = 2003 | title = Schizophrenia: a conceptual history | url = | journal = International Journal of Psychology and Psychological Therapy | volume = 3 | issue =2 | pages = 111–140 }}</ref>。
[[File:Chlorpromazine-3D-vdW.png|thumb]]的分子結構圖，其在20世紀50年代使精神分裂症的治療徹底改變。]]
「Schizophrenia」一词可以直譯作「分裂的心智」，它的[[希腊语|希腊词根]]是schizein（撕裂）和phren（心智）<ref>{{cite journal |author=Kuhn R |title=Eugen Bleuler's concepts of psychopathology |journal=History of Psychiatry|volume=15 |issue=3 |year=2004 |pages=361–6 |doi=10.1177/0957154X04044603 |pmid=15386868 |others=tr. Cahn CH}}</ref>，以往中國大陸、台灣和香港的名稱「精神-{}-分裂-{}-症」皆是直譯此而來<ref name="直譯"/>，台灣後來則改稱為「思覺失-{}-調症」<ref name="更名"/>。尤金·布魯勒于1908年第一次提出了这个概念，用来描述[[人格心理學|人格]]、[[思想|思想]]、[[记忆|记忆]]、[[知觉|知觉]]之间的功能分离。美國人和英國人把布魯勒的宣稱理解成他在形容精神分裂症的「4A」症狀：情緒淡然（flattened Affect）、自閉（Autism）、聯想障礙（impaired Association）、情感矛盾（Ambivalence）。<ref name="fn_78">{{cite journal |author=Stotz-Ingenlath G |title=Epistemological aspects of Eugen Bleuler's conception of schizophrenia in 1911 |journal=Medicine, Health Care and Philosophy |volume=3 |issue=2 |pages=153–9 |year=2000 |pmid=11079343|url=http://www.kluweronline.com/art.pdf?issn=1386-7423&volume=3&page=153|format=PDF |doi=10.1023/A:1009919309015}}</ref><ref>{{cite journal|author=McNally K|title=Eugen Bleuler's "Four A's"|journal=History of Psychology|year=2009|volume=12|pages=43–59|doi=10.1037/a0015934|pmid=19831234|issue=2}}</ref>布魯勒意識到這一種疾病並不是癡呆症，因為他的一些患者的病情是在改善，而不是惡化，因此提議以「Schizophrenia」稱呼這一疾病。在50年代中期，因氯丙嗪的研發和引入，而使精神分裂症的治療徹底改變。<ref name="Turner2007">{{cite journal | author=Turner T | title=Unlocking psychosis | journal=British Medical Journal | year=2007 | volume=334 | issue=suppl | pages=s7 | doi=10.1136/bmj.39034.609074.94 | pmid=17204765 }}</ref>

在20世紀70年代初，精神分裂症的診斷標準出現了不少爭議，最終修訂成現今所使用的標準。1971年美英诊断学大会发现[[美国|美国]]的思覺失調症患者要比[[欧洲|欧洲]]多很多<ref name="Wing1971">{{cite journal |author=Wing JK |title=International comparisons in the study of the functional psychoses |journal=British Medical Bulletin |volume=27 |issue=1 |pages=77–81 |date=1971-01  |pmid=4926366}}</ref>，部分是因為美国使用的DSM-II诊断标准比起欧洲的ICD-9更为宽松。{{link-en|大衛·羅森漢|David Rosenhan}}於1972年進行並於《科學》期刊發表的著名研究——《[[罗森汉恩实验|精神病房里的正常人]]》（On being sane in insane places），指出美国的思覺失調症诊断标准往往过于主觀且不可靠<ref>{{cite journal |author=Rosenhan D |year=1973 |title=On being sane in insane places |journal=[[Science_(journal)|Science]] |volume=179 |pages=250–8 |pmid=4683124| doi=10.1126/science.179.4070.250 |issue=4070|bibcode=1973Sci...179..250R }}</ref>。這項研究不僅使精神分裂症的診斷标准得以修正，還令整本DSM手冊得以修訂，使得美國精神醫學學會於1980年时出版[[DSM-III|DSM-III]]<ref name="Wilson1993">{{cite journal |author=Wilson M |title=DSM-III and the transformation of American psychiatry: a history |journal=American Journal of Psychiatry |volume=150 |issue=3 |pages=399–410 |date=1993-03  |pmid=8434655 |doi=10.1176/ajp.150.3.399}}</ref>。

「精神-{}-分裂-{}-症」這一用語通常誤解成受其影響的人擁有「多重的人格」。雖然一些診斷出精神分裂症的人可能會聽見不存在的聲音，並把其視為獨特的人格，但精神分裂症並不牽涉到在多個人格中轉換。這一種混淆的想法部分可歸因於布魯勒的用語「精神-{}-分裂-{}-症」的字面解釋（布魯勒最初將精神分裂症與解離症狀聯繫
起來，並且在他的精神分裂症分類中包含人格分裂）<ref>{{cite journal | author = Stotz-Ingenlath G | year = 2000 | title = Epistemological aspects of Eugen Bleuler's conception of schizophrenia in 1911 | url = | journal = Med Health Care Philos | volume = 3 | issue = 2| pages = 153–159 | pmid = 11079343 | doi=10.1023/A:1009919309015}}</ref><ref name=mhpsampd>{{cite journal |author1=Hayes J. A. |author2=Mitchell J. C. | year = 1994 | title = Mental health professionals' skepticism about multiple personality disorder | url = | journal = Professional Psychology: Research and Practice | volume = 25 | issue = 4| pages = 410–415 | doi=10.1037/0735-7028.25.4.410}}</ref>。在DSM-II中，[[解離性人格疾患|解離性人格疾患]]也常常誤診成精神分裂症，因為其標準診斷較為寬鬆<ref name=mhpsampd/><ref>Putnam, Frank W. (1989). Diagnosis and Treatment of Multiple Personality Disorder. New York: The Guilford Press. pp. 351. ISBN 0-89862-177-1</ref>。第一位已知誤用該詞的人是一名叫[[托馬斯·斯特恩斯·艾略特|托馬斯·斯特恩斯·艾略特]]的詩人，在他於1933年所寫的文章中誤用「人格分裂」一詞<ref name="fn_3">{{cite book|author1=Berrios, G. E. |author2=Porter, Roy |title=A history of clinical psychiatry: the origin and history of psychiatric disorders |publisher=Athlone Press |location=London |year=1995 |isbn=0-485-24211-7}}</ref>。其他學者則追溯到更早的誤用根源<ref>{{cite journal|author=McNally K|title=Schizophrenia as split personality/Jekyll and Hyde: the origins of the informal usage in the English language|journal=Journal of the history of the behavioral sciences|date=Winter 2007|volume=43|issue=1|pages=69–79|pmid=17205539|doi=10.1002/jhbs.20209}}</ref>。

== 社会和文化 ==
{{See also|精神分裂症患者列表}}
[[File:John_Forbes_Nash,_Jr._by_Peter_Badge.jpg|thumb]]是一名美國數學家兼1994年諾貝爾經濟學獎共同獲得者之一，他亦是一名精神分裂症患者。他的一生改編成一部獲得[[奧斯卡獎|奧斯卡獎]]的電影——《[[美丽心灵|美丽心灵]]》（另譯成《美麗境界》）]]
2002年，日本把這一種疾病的名稱由「{{jp|j=精神-{}-分-{}-裂病|rm=seishin-bunretsu-byō}}」改名为「{{jp|j=統合失調症|rm=tōgō-shitchō-shō}}」，以減少疾病名稱所帶來的社會污名<ref>{{cite journal |author1=Kim Y |author2=Berrios GE |title=Impact of the term schizophrenia on the culture of ideograph: the Japanese experience |journal=Schizophr Bull |volume=27 |issue=2 |pages=181–5 |year=2001 |pmid=11354585 |doi=10.1093/oxfordjournals.schbul.a006864}}</ref>，此一名字的靈感是來自生物－心理－社會模型的，且在實行三年內把接受診斷的人數從37％增加到70％<ref name="Sato">{{cite journal |author=Sato M |year=2004 |title=Renaming schizophrenia: a Japanese perspective |journal=World Psychiatry |volume=5 | issue=1 |pages=53–55 |pmid=16757998 |pmc=1472254}}</ref>。2012年在韓國亦發生了類似的變化<ref>{{cite journal|author1=Lee YS |author2=Kim JJ |author3=Kwon JS |title=Renaming schizophrenia in South Korea|journal=The Lancet|volume=382|issue=9893|pages=683–684|doi=10.1016/S0140-6736(13)61776-6|pmid=23972810|date=2013-08}}</ref>。2014年，[[中華民國衛生福利部|中華民國衛生福利部]]宣佈將「精神-{}-分裂-{}-症」正式更名為「思覺-{}-失調-{}-症」<ref name="更名"/>，此一名稱是考慮到此疾病的核心表現性質——「思考」及「知覺」<ref>{{Cite web|url=http://hospital.kingnet.com.tw/essay/essay.html?pid=41635 |title=精神分裂症正名為「思覺失調症」新一代抗精神病藥物有助生活品質 |publisher=KingNet國家網路醫藥 |author=陳大申 |date=2014-06-21 |accessdate=2016-11-28 |deadurl=no |archiveurl=https://web.archive.org/web/20161128195741/http://hospital.kingnet.com.tw/essay/essay.html?pid=41635 |archivedate=2016-11-28 }}</ref>。精神病學教授{{link-en|吉姆·范·奧斯|Jim van Os}}則建議把英語的「Schizophrenia」（精神分裂症）改名為「psychosis spectrum syndrome」（精神病類群障礙症）<ref>{{cite journal|last1=van Os|first1=Jim |title='Schizophrenia' does not exist|journal=BMJ|date=2016-02-02|pages=i375|doi=10.1136/bmj.i375}}</ref>。

在2002年的美國，精神分裂症的耗用成本估計為627億美元，當中計算了直接成本（門診、住院、藥物和長期護理）和非醫療保健成本（執法、生產率下降和失業）<ref>{{cite journal |author=Wu EQ |year=2005 |title=The economic burden of schizophrenia in the United States in 2002 |journal=J Clin Psychiatry |volume=66 | issue=9 |pages=1122–9|pmid=16187769 |doi=10.4088/jcp.v66n0906}}</ref>。《[[美丽心灵|美丽心灵]]》（「A Beautiful Mind」，另譯成《美麗境界》）是一部描写约翰·福布斯·纳什（John Forbes Nash Jr.）的生平电影以及書籍：他是一名罹患思覺失調症的[[诺贝尔經濟學奖|诺贝尔經濟學奖]]得主<ref>{{cite news|author=李文 |title=新聞人物：「美麗心靈」數學家約翰·納什 |url=http://www.bbc.com/zhongwen/trad/world/2015/05/150524_profile_nash |publisher=BBC |date=2015-05-24 |accessdate=2016-11-28 |deadurl=no |archiveurl=https://web.archive.org/web/20161128203917/http://www.bbc.com/zhongwen/trad/world/2015/05/150524_profile_nash |archivedate=2016-11-28 }}</ref>。有「中国的梵高」之稱的[[沙耆|沙耆]]亦同樣是精神分裂症患者，但他在發病之後仍在[[沙耆故居|藜斋]]不停画画，其後他的画作受畫壇賞識，在1980年代一幅画作的價格更高達數万人民幣<ref>{{cite news|author=毛艳艳|author2=谢国旗 |title=沙耆故居：宁静藜斋护天真|url=http://www.nbwb.net/info.aspx?Id=2577|work=东南商报|publisher=宁波文化遗产保护网 |date=2007-02-05|accessdate=2016-11-30}}</ref>。

===暴力===
患有嚴重精神疾病的人受到暴力或非暴力對待的風險會顯著增加，包括患有精神分裂症<ref>{{cite journal |author=Maniglio R |title=Severe mental illness and criminal victimization: a systematic review |journal=Acta Psychiatr Scand |volume=119 |issue=3 |pages=180–91 |date=2009-03  |pmid=19016668 |doi=10.1111/j.1600-0447.2008.01300.x }}</ref>。精神分裂症亦與較常使用暴力有關，但這主要是因為患者的[[物質濫用|吸毒率]]較高<ref name=Fazel>{{cite journal |author1=Fazel S |author2=Gulati G |author3=Linsell L |author4=Geddes JR |author5=Grann M |title=Schizophrenia and violence: systematic review and meta-analysis |journal=PLoS Med. |volume=6 |issue=8 |pages=e1000120 |date=2009-08  |pmid=19668362 |pmc=2718581 |doi=10.1371/journal.pmed.1000120 }}</ref>。與精神病相關的[[杀人|兇殺]]率類似於與物質濫用相關的，且在一個地區內比例會差不多<ref>{{cite journal |author1=Large M |author2=Smith G |author3=Nielssen O |title=The relationship between the rate of homicide by those with schizophrenia and the overall homicide rate: a systematic review and meta-analysis |journal=Schizophr. Res. |volume=112 |issue=1–3 |pages=123–9 |date=2009-07  |pmid=19457644 |doi=10.1016/j.schres.2009.04.004 }}</ref>。若把精神分裂症跟物質濫用分開看待後，其在使用暴力上扮演了什麽角色仍是具一定爭議性，但個人經歷或精神狀態的某些層面可能是使用暴力的其中一些因素<ref>{{cite journal |author1=Bo S |author2=Abu-Akel A |author3=Kongerslev M |author4=Haahr UH |author5=Simonsen E |title=Risk factors for violence among patients with schizophrenia |journal=Clin Psychol Rev |volume=31 |issue=5 |pages=711–26 |date=2011-07  |pmid=21497585 |doi=10.1016/j.cpr.2011.03.002 }}</ref>。約11％服刑中的兇殺者患有精神分裂症，21％的人則患有情緒障礙<ref name=Alex2006/>。另一項研究發現，在研究進行的前一年內，約8-10％的精神分裂症患者對他人行使了暴力，而普通人口的比例則為2％<ref name=Alex2006>{{cite journal|first1=Alexandre Martins |last1=Valença |first2=Talvane Marins |last2=de Moraes |title=Relationship between homicide and mental disorders |url=https://www.ncbi.nlm.nih.gov/pubmed/17143446 |journal=Revista Brasileira De Psiquiatria (Sao Paulo, Brazil: 1999) |date=2006-10-01 |issn=1516-4446 |pages=S62–68 |volume=28 Suppl 2 |pmid=17143446 |deadurl=no |archiveurl=https://web.archive.org/web/20161124160107/https://www.ncbi.nlm.nih.gov/pubmed/17143446 |archivedate=2016-11-24 }}</ref>。

與患者行使暴力相關的報導加強了公眾認知中精神分裂症與暴力的聯繫<ref name= Fazel/>。一項在1999年進行的大型調查顯示，12.8％的美國人認為精神分裂症患者「很有可能」對他人行使暴力，48.1％的人則表示他們「有一點可能」會這樣做。超過74％的人說患者「不太能」或「不能全部地」作出與治療有關的決定，70.2％的人說金錢管理上的決定亦如是。<ref>{{cite journal |author1=Pescosolido BA |author2=Monahan J |author3=Link BG |author4=Stueve A |author5=Kikuzawa S |title=The public's view of the competence, dangerousness, and need for legal coercion of persons with mental health problems |journal=American Journal of Public Health |volume=89 |issue=9 |pages=1339–45 |date=1999-09 |pmid=10474550 |pmc=1508769 |doi= 10.2105/AJPH.89.9.1339}}</ref>根據一項薈萃分析顯示，自1950年代以來，行使暴力的精神病患者已經上升了不止一倍<ref>{{cite journal |author1=Phelan JC |author2=Link BG |author3=Stueve A |author4=Pescosolido BA |date=2000-06  |title=Public Conceptions of Mental Illness in 1950 and 1996: What Is Mental Illness and Is It to be Feared? |journal=Journal of Health and Social Behavior |volume=41 |issue=2 |pages=188–207 |doi=10.2307/2676305}}</ref>。

==研究方向==
初步研究證實，[[米諾環素|米諾環素]]對患者病情的改善有一些效果<ref>{{cite journal|author1=Dean OM |author2=Data-Franco J |author3=Giorlando F |author4=Berk M |title=Minocycline: therapeutic potential in psychiatry|journal=CNS Drugs|date=2012-05-01|volume=26|issue=5|pages=391–401|pmid=22486246|doi=10.2165/11632000-000000000-00000}}</ref>。亦有關於硝化療法及努力改善患者的生活環境的研究，用以改善他們能力上的缺陷；然而目前為止還沒有足夠的證據去對其有效性作出結論<ref>{{cite journal|author=Chamberlain IJ, Sampson S|title=Nidotherapy for people with schizophrenia|journal=Cochrane Database of Systematic Reviews|date=2013-03-28|volume=3|issue=3|pages=CD009929|pmid=23543583|doi=10.1002/14651858.CD009929.pub2|editor1-last=Chamberlain|editor1-first=Ian J}}</ref> 。研究人員已證實陰性症狀是會對治療産生挑戰，因為它們通常不能透過藥物治療改善。他們亦因此對各種藥劑進行了研究，以確定它們可能帶來的效果<ref>{{cite journal|author1=Chue P |author2=LaLonde JK |year=2014|title=Addressing the unmet needs of patients with persistent negative symptoms of schizophrenia: emerging pharmacological treatment options|journal=Neuropsychiatr Dis Treat.|volume=10|pages=777–89|pmc=4020880|doi=10.2147/ndt.s43404|pmid=24855363}}</ref>，並基於在病理學上，炎症可能對精神分裂症起了一定作用，所以已有針對擁有抗炎活性的藥物的研究<ref>{{cite journal|author1=Keller WR |author2=Kum LM |author3=Wehring HJ |author4=Koola MM |author5=Buchanan RW |author6=Kelly DL. |year=2013|title=A review of anti-inflammatory agents for symptoms of schizophrenia|journal=J Psychopharmacol.|volume=27|issue=4|pages=337–42|pmid=23151612|doi=10.1177/0269881112467089}}</ref>。

== 參考文獻 ==
{{Reflist|30em}}

==參見==
*{{le|經顱磁刺激|Transcranial magnetic stimulation}}

==外部連結==
* {{dmoz|Health/Mental_Health/Disorders/Schizophrenia/}}
{{-}}
{{ICD-10-F}}
{{染色体8}}

{{Authority control}}
{{portal bar|醫學|神經科學|社會學|身心障礙}}
[[Category:精神病|Category:精神病]]
[[Category:精神病学诊断|Category:精神病学诊断]]
[[Category:精神分裂症|Category:精神分裂症]]
[[Category:精神病理學|Category:精神病理學]]
{{Good article}}